<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Degener Neurol Neuromuscul Dis</journal-id><journal-id journal-id-type="iso-abbrev">Degener Neurol Neuromuscul Dis</journal-id><journal-id journal-id-type="publisher-id">dnnd</journal-id><journal-title-group><journal-title>Degenerative Neurological and Neuromuscular Disease</journal-title></journal-title-group><issn pub-type="epub">1179-9900</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8051957</article-id><article-id pub-id-type="publisher-id">299589</article-id><article-id pub-id-type="doi">10.2147/DNND.S299589</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia</article-title><alt-title alt-title-type="running-authors">Alzobaidi et al</alt-title><alt-title alt-title-type="running-title">Alzobaidi et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alzobaidi</surname><given-names>Nafaa</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Quasimi</surname><given-names>Huma</given-names></name><xref ref-type="aff" rid="aff0002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1852-7778</contrib-id><name><surname>Emad</surname><given-names>Nasr A</given-names></name><xref ref-type="aff" rid="aff0003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7985-4241</contrib-id><name><surname>Alhalmi</surname><given-names>Abdulsalam</given-names></name><xref ref-type="aff" rid="aff0004"><sup>4</sup></xref><xref ref-type="corresp" rid="an0001"/></contrib><contrib contrib-type="author"><name><surname>Naqvi</surname><given-names>Maaz</given-names></name><xref ref-type="aff" rid="aff0001"><sup>1</sup></xref></contrib><aff id="aff0001"><label>1</label><institution>Department of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard</institution>, <addr-line>New Delhi</addr-line>, <country>India</country></aff><aff id="aff0002"><label>2</label><institution>Department of Physiology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard</institution>, <addr-line>New Delhi</addr-line>, <country>India</country></aff><aff id="aff0003"><label>3</label><institution>Department of Pharmaceutics, School of Pharmaceutical Education &#x00026; Research, Jamia Hamdard</institution>, <addr-line>New Delhi</addr-line>, <country>India</country></aff><aff id="aff0004"><label>4</label><institution>Department of Pharmaceutics, College of Pharmacy, Aden University</institution>, <addr-line>Aden</addr-line>, <country>Yemen</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Abdulsalam Alhalmi <institution>Department of Pharmaceutics, College of Pharmacy, Aden University</institution>, <addr-line>Aden</addr-line>, <country>Yemen</country> Email aa.abdulla@pharm.adenuniv.com</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>11</volume><fpage>1</fpage><lpage>14</lpage><history><date date-type="received"><day>06</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>23</day><month>3</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 Alzobaidi et al.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Alzobaidi et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><title>Abstract</title><p>Dementia is a term that encompasses a group of clinical symptoms affecting memory, thinking and social abilities, characterized by progressive impairment of memory performance and cognitive functions. There are several factors involved in the pathogenesis and progression of dementia, such as old age, brain ischemia, toxin exposure, and oxidative stress. There are extensive similarities between dementia and Alzheimer&#x02019;s disease (AD) either in clinical manifestations or experimental animal models. AD is the most dominant form of dementia, characterized by the accumulation of beta-amyloid protein and cholinergic neurotransmission deficits in the brain. Currently available medications for the treatment of dementia, such as choline esterase inhibitors, N-methyl-D-aspartate (NMDA) antagonists (memantine), have short-term efficacy and only relieve symptoms rather than targeting the main underlying pathogenesis. Several animal studies and clinical trials are being conducted to provide a rational approach to these medicinal plants in the prevention or treatment of memory deficits. This review highlights the potential effects of medicinal plants and their derived lead molecules, and explains the related mechanisms and effects reviewed from published literature as major thrust aspects and hopeful strategies in the prevention or treatment of dementia.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>cognitive impairment</kwd><kwd>Alzheimer&#x02019;s disease</kwd><kwd>vascular dementia</kwd><kwd>dementia</kwd><kwd>medicinal plants</kwd><kwd>bioactive compounds</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>no funding</institution></institution-wrap></funding-source></award-group><funding-statement>There is no funding to report.</funding-statement></funding-group><counts><fig-count count="2"/><ref-count count="125"/><page-count count="14"/></counts></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>Dementia is a term that encompasses a group of clinical symptoms affecting memory, thinking and social abilities, characterized by progressive impairment of memory performance and cognitive functions. It has emerged as a major social and medical challenge that calls for urgent measures to establish its underlying pathogenesis and therapeutic interventions. There are several factors involved in the pathogenesis and progression of dementia, such as old age, brain ischemia, toxin exposure, and oxidative stress. Globally, around 50 million people are believed to be lived with dementia, with nearly 7.7 million new annual cases. The majority of them are poorly diagnosed and belong to low- and middle-income countries.<xref rid="cit0001" ref-type="bibr">1</xref> Dementia is considered one of the most common causes of death in high-income countries.<xref rid="cit0002" ref-type="bibr">2</xref> Although dementia is usually considered a disease of the elderly, the number of cases between 40 and 60 years of age rises rapidly.<xref rid="cit0003" ref-type="bibr">3</xref> In spite of the rapid progress in the development of synthetic drugs targeting memory loss, the demand for alternative or complementary medicine is also growing globally, and it should be given great attention. Herein, we review the pivotal role of common medicinal plants, which are widely used in various traditional systems of medicine as potential preventative or treatment strategies against dementia.</p></sec><sec id="s0002"><title>Pathogenesis of Dementia</title><p>Substance abuse, subdural hematoma, intracranial tumors, neuro-infection, amyotrophic lateral sclerosis, and other neurodegenerative disorders are common causes of vascular dementias.<xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0005" ref-type="bibr">5</xref> AD is the most dominant form of dementia, characterized by accumulation of beta-amyloid (amyloid plaques) and progressive microtubule disintegration, leading to synaptic loss, dysfunctional communication and neuronal cell apoptosis. Moreover, the &#x003b2;-amyloid plaques (insoluble proteins) accumulate between the neurons and interact with cell membranes, which trigger the oxidative stress and free calcium levels, and eventually lead to neuronal cell death. Pesticides, air pollutants and industrial toxic chemicals that easily penetrate blood-brain barriers can induce oxidative stress, neuronal damage and increase the progression of dementia.<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0007" ref-type="bibr">7</xref> Autosomal genetic mutation in the central nervous system (CNS) is an important inherent factor associated with the early onset of AD.<xref rid="cit0008" ref-type="bibr">8</xref> In the absence of definitive and effective treatment for dementia, lifestyle modification, phytopharmaceuticals, physical exercise, and practicing cognitive and social activities are considered effective means for disease treatment and prevention.<xref rid="cit0009" ref-type="bibr">9</xref> Some drugs approved by the FDA are currently used for dementia management, but they were reported to have several adverse effects. Therefore, it is necessary to explore safer strategies from evidence-based medicine that can control dementia (<xref ref-type="fig" rid="f0001">Figure 1</xref>).<fig id="f0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Illustrative diagram showing the potential mechanisms of bioactive compounds against dementia.</p></caption><graphic content-type="print-only" xlink:href="DNND-11-1-g0001"/></fig></p></sec><sec id="s0003"><title>Medicinal Plants and Bioactive Compounds: An Alternative Therapeutic Strategy for Dementia Treatment</title><p>Aging or cognitive diseases are characterized by amyloid protein deposition and cholinergic neurotransmission deficits in the brain. Unfortunately, currently available dementia treatments, such as choline esterase inhibitors, N-methyl-D-aspartate (NMDA) antagonists (memantine), and calcium channel blockers, have short-term efficacy, and only relieve symptoms rather than targeting the main underlying pathogenesis.<xref rid="cit0010" ref-type="bibr">10</xref> Memantine is a relatively weak NMDA receptor antagonist, approved for AD by the FDA in 2003, given to patients with moderate to severe cognitive deficits, and is known to prevent neuronal damage and synaptic loss caused by upregulation of NMDA receptors.<xref rid="cit0011" ref-type="bibr">11</xref> As conventional therapies have many side effects and fail to improve cognitive decline, natural products and non-pharmacological interventions appear to be promising and safer alternative approaches with a beneficial impact on cognitive behaviors, thus they should be central strategies in the treatment of memory impairment.</p></sec><sec id="s0004"><title><italic>Ginkgo biloba</italic> (Gb) L</title><p><italic>Ginkgo biloba</italic> (Gb) is one of the most distinctive plants of the Ginkgoaceae family. Gb possesses a large genome, and it has high resistance to plant pathogens and other environmental factors, such as intense sunlight, temperature, high soil salinity, and so on.<xref rid="cit0012" ref-type="bibr">12</xref> Gb has been widely used for the treatment of various neurovascular disorders, such as vertigo, tinnitus, venous insufficiency, fatigue and age-related physical and cognitive disorders.<xref rid="cit0013" ref-type="bibr">13</xref> EGb761, is a standard Gb extract, contains a mixture of flavonoids (primarily quercetin, kaempferol, and isorhamnetin) and terpenoids (2.8&#x02013;3.4% ginkgolides A, B, and C, and 2.6&#x02013;3.2% bilobalide). It has been extensively studied as an effective treatment for memory impairment. Also, it has been reported as an effective therapy against a wide variety of CNS disorders, such as depression, anxiety, stroke, and cerebral insufficiency.<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0015" ref-type="bibr">15</xref> Gb extract has potential therapeutic effects on ischemic brain injury, cognitive and neurological disorders by improving cerebral perfusion and inhibiting platelet-activating factors. Flavonoids and terpene lactones like ginkgolides and bilobalides are the most isolated phytoconstituents from Gb extract. A standardized Gb extracts effectively reduced tissue damage after brain ischemia, attenuated oxidative stress, and improved cognitive dysfunction in various experimental rat models of dementia and chronic stress.<xref rid="cit0016" ref-type="bibr">16&#x02013;18</xref> An in vitro study evaluated the antiplatelet activity of EGb761 and concluded that Gb extract has protective effects and functional integrity on cerebral microvascular endothelial cells.<xref rid="cit0019" ref-type="bibr">19</xref> Cell line studies showed that Gb extract protected cultured brain cells against neurotoxicants like nitric oxide<xref rid="cit0020" ref-type="bibr">20</xref> and cyanide.<xref rid="cit0021" ref-type="bibr">21</xref> Oral or intraperitoneal administration of 10&#x02013;100 mg/kg of Gb extract prevented neuronal damage caused by transient middle cerebral artery occlusion (MCAO) in rats.<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0022" ref-type="bibr">22</xref> In one model of vascular dementia in gerbils, EGb761 significantly improved spatial learning and memory, protected the hippocampal CA1 neurons and increased SOD activity in plasma.<xref rid="cit0023" ref-type="bibr">23</xref> Chronic administration of Gb leaf extract protected rats&#x02019; brain against biochemical and degenerative changes induced by aluminum chloride through increasing endogenous antioxidant and inhibiting the formation of free radicals.<xref rid="cit0024" ref-type="bibr">24</xref> Additionally, treatment with Gb extract has been found to display antioxidant and neuroprotective activities on the prefrontal cortex and dorsal hippocampus of middle-aged rats. The study showed that chronic treatment with Gb extract improved age-related memory impairment and increased the survival of cortical neurons.<xref rid="cit0025" ref-type="bibr">25</xref> In a randomized, placebo-controlled clinical trial, the study findings showed that daily administration of 240 mg of Gb extract was safe and effective in the treatment of patients with dementia.<xref rid="cit0026" ref-type="bibr">26</xref> Furthermore, a meta-analysis study by Wang et al proved that Gb could be an effective treatment for vascular dementia.<xref rid="cit0027" ref-type="bibr">27</xref> Another meta-analysis study explored the efficacy of EGb 761 in dementia patients treated with 120 mg or 240 mg per day when compared to placebo. The study results showed that EGb 761 was well tolerated in all trials and that 240 mg of EGb 761 was more effective in improving cognition.<xref rid="cit0028" ref-type="bibr">28</xref> In contrast, the findings of a randomized, controlled trial demonstrated that 120 mg of Gb extract twice a day is not effective in reducing either the incidence rate of dementia or AD in elderly individuals aged &#x02265;75 years with normal cognition or those with mild cognitive impairment (MCI).<xref rid="cit0029" ref-type="bibr">29</xref></p><p><italic>G. biloba</italic> has a high cerebral bioavailability, a single dose of EGb761<sup>&#x000ae;</sup> (90 mg/kg) reaches its peak concentration after 1 hour and remains at measurable levels for 6 hours in rats&#x02019; brain.<xref rid="cit0030" ref-type="bibr">30</xref> Despite the safety and efficacy data of Gb in improving cognition, the co-administration of Gb with antipsychotic drugs like risperidone, phenytoin, or trazodone has been resulted in serious neurological side effects.<xref rid="cit0031" ref-type="bibr">31</xref> Additional animal studies and clinical trials are required to assess the safety aspect and the potential interaction with other drugs.</p></sec><sec id="s0005"><title><italic>Withania somnifera</italic> (Ashwagandha)</title><p><italic>Withania somnifera</italic> or Ashwagandha or Indian Ginseng (fam. Solanaceae) is a popular Ayurvedic medicinal plant known for its adaptogenic and antistress effects. Ashwagandha is an essential ingredient in Thai traditional medicine; it is used for enhancing memory and body functions. The roots of <italic>W. somnifera</italic> contain several phytoconstituents such as alkaloids, withanolides, sitoindosides and flavonoids. Among these compounds, withaferin A is a molecule of interest that has shown a neuroprotective effect in various human and animal studies. The immunomodulatory and antioxidant potentials of these bioactive candidates have been explored in an experimental model of acute stress.<xref rid="cit0032" ref-type="bibr">32</xref> Some of the plausible mechanisms of action of <italic>W. somnifera</italic> against AD are (i) blocking &#x003b2;-amyloid (A&#x003b2;) production; (ii) inhibition of NF-&#x003ba;B pathway; (iii) reduction of neuronal death; (iv) modulation of synaptic transmission and restoring antioxidant enzymes.<xref rid="cit0033" ref-type="bibr">33</xref> Kuboyama et al have evaluated the effect of withanoside IV on memory improvement and synaptic reconstruction in A&#x003b2;<sub>25&#x02013;35</sub> induced injury on cultured rat cortical neurons. The study findings revealed that oral administration of withanoside IV (10 micromole/kg/day) markedly induced neurite outgrowth, restored memory defects, and protected mice from axonal, dendritic and synaptic loss.<xref rid="cit0034" ref-type="bibr">34</xref> In a preliminary placebo-controlled trial, Chengappa et al have studied the cognitive impact of standardized <italic>W. somnifera</italic> extract against bipolar disease. The researchers observed that <italic>W. somnifera</italic> extract (500 mg/day) significantly enhanced the cognitive tests and improved auditory-verbal working memory.<xref rid="cit0035" ref-type="bibr">35</xref></p></sec><sec id="s0006"><title><italic>Panax ginseng</italic> C.A. Meyer (Ginseng)</title><p>Ginseng is a slow-growing perennial herb (Family of Araliaceae; a genus of <italic>Panax</italic>), widely cultivated in northeastern China. In the last decade, many experimental studies have shown that this plant has a key function in preventing neurodegeneration and improving learning and memory deficits.<xref rid="cit0036" ref-type="bibr">36</xref> Ginseng is an adaptogen, protects against various biological stressors. Ginsenosides, the most valuable active constituents in <italic>Panax ginseng</italic> roots, are known to have a wide range of pharmacological activities including anti-inflammatory, antioxidant, immunomodulatory, anti-cancer, anti-aging, and adaptogenic activities. Zhang et al studied the neuroprotective potential of ginsenoside Rg2 on memory impairment in a vascular dementia (VD) in a rat model of cerebral ischemic reperfusion. The study results indicated that a significant improvement in cognitive abilities and neurological responses in the ginsenoside Rg2 group relative to the disease control group.<xref rid="cit0037" ref-type="bibr">37</xref> A significant reduction in A&#x003b2;<sub>40</sub> and A&#x003b2;<sub>42</sub> levels in the brains of transgenic mice and cultured neurons was demonstrated after treatment with ginsenoside Rg3.<xref rid="cit0038" ref-type="bibr">38</xref> Ginsenoside Rg5 has been tested and found to modulate cognitive dysfunction, neuroinflammation, and increased cholinergic activity in streptozotocin (STZ)-induced memory impairment in rats.<xref rid="cit0039" ref-type="bibr">39</xref> Hur et al patented a pharmaceutical composition containing ginsenoside Rg18, it has neuroprotective activity against A&#x003b2;-induced nerve cell death during brain inflammation.<xref rid="cit0040" ref-type="bibr">40</xref> This invention produced a significant improvement of memory and learning skills using a model of A&#x003b2; peptide to induce dementia.<xref rid="cit0040" ref-type="bibr">40</xref> Ginsenoside Rg1 modulates the neurotransmission and enhances glutamate release in the CNS through a calcium/calmodulin-dependent protein kinase II-dependent signaling pathway.<xref rid="cit0041" ref-type="bibr">41</xref> In a randomized controlled trial, recruited 61 AD patients, Mini-Mental State Examination (MMSE) and Alzheimer&#x02019;s Disease Assessment Scale&#x02013;Cognitive Subscale (ADAS-Cog) tests were used to assess the changes in cognitive and functional performance after chronic oral administration of Korean red ginseng (KRG) as an adjuvant treatment for dementia. The study results demonstrated that the ADAS and Clinical Dementia Rating Scale (CDR) were improved markedly after 24 weeks in the high-dose (9 g/day) KRG treated patients relative to those in the control group.<xref rid="cit0042" ref-type="bibr">42</xref> Briefly, the active constituents of <italic>Panax ginseng</italic> play a crucial role in the regulation of amyloid-&#x003b2; synthesis, acetylcholine signaling and neuro-inflammatory response. Thus, they could be potential candidates in the treatment of dementia and AD.</p></sec><sec id="s0007"><title><italic>Curcuma longa</italic> (Turmeric)</title><p><italic>Curcuma longa</italic> L. is a tuberous herbaceous perennial plant with yellow flowers and wide leaves, belongs to the <italic>Zingiberaceae</italic> family, and grows in the tropical climate. Curcumin (diferuloylmethane) and curcuminoid analogs such as demethoxycurcumin and bisdemethoxycurcumin are the main bioactive components in the rhizome of <italic>Curcuma longa</italic>, and commonly used as natural coloring agents in food. In traditional Indian medicine, turmeric is widely used for the treatment of many pathological conditions, such as asthma, epilepsy, gallstone and diabetic.<xref rid="cit0043" ref-type="bibr">43</xref> As previously described, neuroinflammation is one of the key causes of cognitive decline. Significant evidence from preclinical and clinical studies elucidated the key role of curcumin in attenuating the neuroinflammatory cytokines, such as monocyte chemoattractant protein 1 (MCP-), TNF-&#x003b1;, IL-6 and TGF-&#x003b2;.<xref rid="cit0044" ref-type="bibr">44</xref> A cell line study conducted by Park et al to assess the neuroprotective mechanisms of curcumin against A&#x003b2;<sub>25&#x02013;35</sub> induced neurotoxicity in PC12 cells. The study findings have shown that curcumin exposure inhibited hyperphosphorylation of microtubule-associated tau proteins, reduced oxidative stress and intracellular calcium influx.<xref rid="cit0045" ref-type="bibr">45</xref> Fluorescence and confocal microscopy were used to measure the A&#x003b2; uptake by the macrophages of AD patients and control individuals. The results showed a significant increase of A&#x003b2; uptake by the macrophages of AD patients compared to curcuminoids-treated and control groups.<xref rid="cit0046" ref-type="bibr">46</xref> Curcumin has been found to enhance glutathione expression, antioxidant enzyme and heme oxygenase in dementia and AD patients.<xref rid="cit0047" ref-type="bibr">47</xref> Agrawal et al studied the effect of curcumin on memory functions, brain insulin receptors (IRs), and acetylcholinesterase (AChE) activity in dementia model in rats. The researchers demonstrated that curcumin could significantly enhance cholinergic activity, attenuate oxidative damage and improve memory deficits in the (STZ)-treated rats compared to controls.<xref rid="cit0048" ref-type="bibr">48</xref> Ganguli et al have noticed lower AD incidence in the Indian population consuming a curcumin-rich diet compared to the US population.<xref rid="cit0049" ref-type="bibr">49</xref> This neuroprotective potential was likely due to attenuation of oxidative stress and reduction of A&#x003b2; deposition, which are the main causes of mitochondrial damage in the brain. Due to the poor oral bioavailability of curcumin, 2000 or 4000 mg/day orally administered curcumin C3 complex (70&#x02013;80% curcumin) has shown a non-significant difference in the clinical efficacy between treatment groups.<xref rid="cit0050" ref-type="bibr">50</xref></p></sec><sec id="s0008"><title><italic>Glycyrrhiza</italic> Genus</title><p><italic>Glycyrrhiza</italic> or liquorice is a perennial herb growing in the Mediterranean region, Asia, Southern Russia, and Iran. <italic>Glycyrrhiza</italic> is derived from ancient Greek, glykys means &#x0201c;sweet,&#x0201d; and rhiza is &#x0201c;root.<xref rid="cit0051" ref-type="bibr">51</xref> Glycyrrhizin is the main active component in liquorice, commonly used as a natural sweetener. In Ayurvedic and Unani medicine, liquorice is extensively used for various medical conditions, such as inflammation of respiratory airways and gastrointestinal tract disorders. Glycyrrhizic acid (GA), a triterpenoid saponin glycoside, has demonstrated its anti-inflammatory and neuroprotective effects in many experimental studies. Isoflavonoid derivatives, including glabrone, lico-isoflavone A and B, glabridine and galbrene, are also essential bio-active components isolated from liquorice extract. Liquiritigenin from <italic>Glycyrrhizae radix</italic> is a selective estrogen receptor-&#x003b2; (ER&#x003b2;) agonist, these receptors are distributed in the brain centers of learning and memory.<xref rid="cit0052" ref-type="bibr">52</xref> Liquiritigenin has shown a good cerebral bioavailability with neuroprotective and anti-inflammatory effects on A&#x003b2;<sub>25&#x02013;35</sub>-induced neurotoxicity on rat hippocampal neurons.<xref rid="cit0053" ref-type="bibr">53</xref> The neuroprotective effects of glycyrrhizin against neurotoxin 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>) have been tested by Soo et al They demonstrated that glycyrrhizin has neuroprotective potential via prevention of mitochondrial damage, attenuation of oxidative stress, and restoration of glutathione depletion in differentiated PC12 cells.<xref rid="cit0054" ref-type="bibr">54</xref> Isoliquiritigenin is another component identified in <italic>Glycyrrhiza</italic> species that can suppress the caspase-3 proapoptotic activity, and produce potential effectiveness against dementia similar to memantine.<xref rid="cit0055" ref-type="bibr">55</xref></p></sec><sec id="s0009"><title>Tea (<italic>Camellia sinensis</italic>)</title><p>Worldwide, green tea, black tea, and oolong tea are popular stimulant drinks. In traditional Indian and Chinese systems of medicine, green tea is also used for the treatment of obesity, diabetes mellitus, and neuro-inflammation.<xref rid="cit0056" ref-type="bibr">56</xref> Here, we searched evidence from animal and human studies showing the crucial role of green tea-related compounds on cognitive functions and memory impairment. (&#x02212;)-epigallocatechin-3-O-gallate (EGCG), is a natural compound contained in green tea extract has anti-atherogenic and anti-inflammatory properties, and plays a key role in the prevention and treatment of neurodegenerative diseases.<xref rid="cit0057" ref-type="bibr">57</xref> In Wistar rat model of dementia, 10 mg/kg/day oral administration of EGCG for 4 weeks significantly reversed the cognitive deficit, reduced oxidative and nitrosative stress, and modulated AChE activity in STZ treated rats.<xref rid="cit0058" ref-type="bibr">58</xref> Lee et al conducted a preclinical study on ICR mice to investigate the effect of EGCG on the systemic neuroinflammation and memory impairment. The study results showed that chronic oral administration of 1.5 and 3 mg/kg EGCG could inhibit lipopolysaccharide (LPS) induced cytokine release and amyloidogenesis, as well as prevent memory impairment, apoptotic neuronal cell death, and microglia activation.<xref rid="cit0059" ref-type="bibr">59</xref></p><p>A prospective cohort study by Tomato et al assessed the cognitive-enhancing action of green tea among Japanese dementia patients aged &#x02265;65 years. The results have shown that more frequent intake of green tea could reduce dementia&#x02019;s incidence rate by 8.7% over 5.7 years of intake.<xref rid="cit0060" ref-type="bibr">60</xref> L-theanine extracted from the leaves of green tea could protect memory deficits and hippocampal cell death by attenuating the neuronal oxidative damage and blocking NF-&#x003ba;B signaling pathway induced by A&#x003b2;<sub>42</sub>.<xref rid="cit0061" ref-type="bibr">61</xref> Several findings from animal and human studies have demonstrated the neuroprotective potential of tea polyphenols, catechins and epicatechin, in improving cognitive decline and neuronal signaling. The potential mechanisms behind that are due to improving the endogenous antioxidant activities, regulation of apoptosis, reduction of A&#x003b2; synthesis, and modulation of mitochondrial function and neural growth factors.<xref rid="cit0062" ref-type="bibr">62&#x02013;64</xref></p></sec><sec id="s0010"><title>Brahmi (<italic>Bacopa monnieri</italic>)</title><p><italic>Bacopa monnieri (L.)</italic> also known as Brahmi, belongs to <italic>Scrophulariaceae</italic> family, it is a creeping, succulent, herb cultivated in the wetlands of the Indian subcontinent.<xref rid="cit0065" ref-type="bibr">65</xref> Brahmi herbs have long been used in Indian Ayurvedic medicine to improve cognitive deficits related to brain aging. It has been demonstrated that Brahmi extract contains bacoside A, which has anti-inflammatory, analgesic, antistress, and antiepileptic actions.<xref rid="cit0066" ref-type="bibr">66</xref> The bacoside metabolites of Brahmi can cross the BBB easily and improve cognition by increasing blood flow, not necessarily due to direct interactions with neural cells. Holcomb et al evaluated the effect of the Brahmi extract on amyloid &#x003b2;-induced AD in PSAPP mice. The study findings revealed that Brahmi extract is able to reduce amyloid plaque in mice cortex, and reverse Y-maze performance and open field hyperlocomotion behavior.<xref rid="cit0067" ref-type="bibr">67</xref> Another study by Limpeanchob et al evaluated the protective effect of Brahmi on A&#x003b2;- induced cell death in primary cortical neurons. The study confirmed that the neuroprotective effect is being due to the suppression of neuronal oxidative stress and enhancing cholinergic activity.<xref rid="cit0068" ref-type="bibr">68</xref> Khan et al found that oral administration of Brahmi extract at 30mg/kg for 14 days significantly improved memory and learning capability, and ameliorated the morphological changes due to oxidative damage induced by intracerebroventricular-streptozotocin (ICV-STZ) in the brain tissue of rats. This neuroprotective effect of Brahmi was attributable to the upregulated expression of hippocampal antioxidant enzymes.<xref rid="cit0069" ref-type="bibr">69</xref> In a mouse model of trimethyltin (TMT)-induced neurodegeneration and cognition dysfunction, administration of 50 mg/kg/day of Brahmi extract significantly protected hippocampal neurons, enhanced neurogenesis, and improved cognitive performance in mice.<xref rid="cit0070" ref-type="bibr">70</xref> Uabundit et al explored beneficial cognitive effects of Brahmi extract against ethyl choline aziridinium ion mediated cognitive decline and neurodegenerative in rats. They observed a decline in both the number and density of cholinergic neurons and improvement in spatial learning and memory.<xref rid="cit0071" ref-type="bibr">71</xref> Bacoside treatment attenuated neurotoxicants (scopolamine, sodium nitrite, and platelet-activating factor antagonist)-induced amnesia, increased cholinergic activity, and reduced latency escape period in mice.<xref rid="cit0072" ref-type="bibr">72</xref> Brahmi has positive effects on the treatment of attention deficit hyperactivity disorder (ADHD) in children and can improve cognitive functions in stroke and epileptic patients.<xref rid="cit0073" ref-type="bibr">73</xref> Among the plausible mechanisms behind the neuroprotective effect of <italic>Brahmi</italic> are increasing glutathione expression and enhancing cerebral blood supply.<xref rid="cit0072" ref-type="bibr">72</xref>,<xref rid="cit0074" ref-type="bibr">74</xref> Oral administration 300&#x02009;mg/day of standardized Brahmi extract in healthy elderly participants for 12 weeks significantly enhanced the cognitive tasks, Rey Auditory Verbal Learning Test (AVLT), Stroop test, and depression scores, confirming its safety and memory-enhancing effects.<xref rid="cit0075" ref-type="bibr">75</xref> A randomized placebo-controlled trial has been conducted in India and enrolled 60 medical students to assess the impact of <italic>Bacopa monnieri</italic> on improving cognition among medical students. 150 mg of standardized Brahmi extract (Bacognize<sup>&#x000ae;</sup>) twice daily for six weeks substantially improved auditory and visual neuropsychological tests and increased serum calcium compared to the control group.<xref rid="cit0076" ref-type="bibr">76</xref> A study performed by Thakkar et al to enhance the poor solubility of Bacognize<sup>&#x000ae;</sup>. Inclusion complex containing 16% bacosides and &#x003b2;-cyclodextrin at a molar ratio of 1:4 by co-precipitation method improved solubility and stability of Bacognize<sup>&#x000ae;</sup> by three times.<xref rid="cit0077" ref-type="bibr">77</xref> Poor learning and ADHD are very common childhood disorders in the Western world. Administration of 10 g Brahmi to 40 rural Indian school children aged 6&#x02013;8&#x02009;years for 3 months significantly enhanced memory and response performance.<xref rid="cit0078" ref-type="bibr">78</xref> Meta-analyses of randomized, double-blind, controlled trials demonstrated the beneficial effects of Brahmi on cognitive performance, particularly attention speed.<xref rid="cit0079" ref-type="bibr">79</xref> In contrast, a study reported that supplementation of Brahmi extract and multiple micronutrients twice daily for 4 months did not show a significant impact in improving short-term memory in Indian school children.<xref rid="cit0080" ref-type="bibr">80</xref> Despite the safety of Brahmi in animal studies and human trials, no studies regarding its safety in pregnancy, so it should not be used.<xref rid="cit0081" ref-type="bibr">81</xref>,<xref rid="cit0082" ref-type="bibr">82</xref></p></sec><sec id="s0011"><title>Nigella sativa</title><p><italic>Nigella sativa</italic> is a small black seed that belongs to the <italic>Ranunculaceae</italic> family, native to Southern Europe, North Africa, and Asia Minor, and it is also cultivated in Pakistan and India. <italic>N. sativa</italic> has long been used in traditional medicine as astringent, diuretic, anthelmintic, and for the treatment of intermittent fever and skin disease.<xref rid="cit0083" ref-type="bibr">83</xref> Moreover, the therapeutic value of N. <italic>sativa</italic> was mentioned in many chapters of the Prophetic medicine book. <italic>N. sativa</italic> contains a variety of constituents, including proteins, alkaloid, alpha-hederin, saponin, vitamins, minerals, volatile and fixed oils. Unsaturated fatty acids represent up to 26.6% to 38% of the total oil content.<xref rid="cit0084" ref-type="bibr">84</xref> Thymoquinone is the molecule of interest attributed to the pharmacological activities of the <italic>N. sativa</italic>.<xref rid="cit0085" ref-type="bibr">85</xref> Thymol and carvacrol attenuated the disruption of cholinergic function and memory deficits induced by A&#x003b2;- and scopolamine in rats.<xref rid="cit0086" ref-type="bibr">86</xref> Emerging evidence confirms that flavonoids of <italic>N.sativa</italic> are able to modulate specific changes in hippocampal protein expression involved in the learning and memory process.<xref rid="cit0087" ref-type="bibr">87</xref> A preclinical study was conducted by Hosseini et al to explore the protective mechanism of <italic>N. sativa</italic> hydroalcoholic extract in scopolamine-induced spatial memory impairment in male Wistar rats. The study results explored that <italic>N. Sativa</italic> purified oils enhanced memory performance, cholinergic activity, and reduced oxidative stress in rat brain tissues.<xref rid="cit0088" ref-type="bibr">88</xref> Similarly, a study performed by Khan et al to evaluate the neuroprotective effect of thymoquinone (3mg/kg body weight) for 15 days against streptozotocin-induced cognitive impairment in rats. The study findings revealed that thymoquinone reduced the levels of oxidative stress markers, and significantly decreased the latency time and the path length in the Morris Water Maze (MWM) test.<xref rid="cit0089" ref-type="bibr">89</xref> Thymoquinone (1.642 mg) ameliorated A&#x003b2;<sub>1&#x02013;42</sub> induced neurotoxicity in rat hippocampal and cortical cultured neurons, and prevented the mitochondrial membrane potential depolarization.<xref rid="cit0090" ref-type="bibr">90</xref> A clinical study by Bin Sayeed et al has investigated the effect of <italic>N. sativa</italic> on anxiety and cognitive decline. The study findings reported that oral intake of <italic>N. sativa</italic> 500 mg/day over four weeks as a nutritional supplement was found to stabilize mood, decrease anxiety and modulate cognition on adolescent human male participants.<xref rid="cit0091" ref-type="bibr">91</xref> Taken together, these collective evidences put thymoquinone in the top list of phytopharmaceuticals as a promising candidate for the treatment of dementia and AD.</p></sec><sec id="s0012"><title>Phytochemicals</title><p>Resveratrol (3,5,4&#x02032;- trihydroxystilbene) belongs to a family of polyphenolic compounds known as stilbenes. Peanuts, pistachios, berries, and grapes are essential sources of resveratrol.<xref rid="cit0092" ref-type="bibr">92</xref> The trans-isomer of resveratrol in the skin of most grape species is more effective and more stable than Cis-isomer. Resveratrol has been shown to exhibit anti-cancer, anti-inflammatory, anti-aging, cardio-protective and anti-oxidant properties.<xref rid="cit0093" ref-type="bibr">93</xref>,<xref rid="cit0094" ref-type="bibr">94</xref> Also, it has anti-amyloidogenic effects and could inhibit the formation and extension of neurotoxic A&#x003b2; fibrils.<xref rid="cit0095" ref-type="bibr">95</xref> A cell line study by Vingtdeux et al studied the potential effect of resveratrol in AD. The investigators observed that resveratrol was able to inhibit the extracellular A&#x003b2; accumulation by facilitating its proteolytic clearance in neuronal cells, and activation of AMP-activated protein kinase in the cerebral cortex of transgenic mice.<xref rid="cit0096" ref-type="bibr">96</xref> In order to enhance the cerebral bioavailability of resveratrol, the development of novel formulations for brain targeting is highly recommended.</p><p>Lycopene is an aliphatic hydrocarbon carotenoid extracted from tomatoes, watermelons, and papayas. It is a strong anti-oxidant, anti-inflammatory, and anti-proliferative agent. Lycopene is well known for its beneficial effects against solid tumors and non-alcoholic fatty liver.<xref rid="cit0097" ref-type="bibr">97</xref>,<xref rid="cit0098" ref-type="bibr">98</xref> Improvement of prostate cancer after a long period of tomato sauce consumption and the prospective association between reduction of plasma glucose level and chronic lycopene intake have been reported in independent clinical studies.<xref rid="cit0099" ref-type="bibr">99</xref>,<xref rid="cit0100" ref-type="bibr">100</xref> The underlying mechanism of lycopene in the treatment of memory deficits is not fully understood. Long-term lycopene intake has been found to inhibit the oxidative stress and reduce infarct volume and neuronal apoptosis in cerebral ischemia/reperfusion in high-fat diet-induced cognitive impairment in rats.<xref rid="cit0101" ref-type="bibr">101</xref> 50 mg/kg of lycopene supplementation for 60 days significantly reduced the levels of inflammatory cytokines, prevented neuronal degeneration and nucleus shrinkage in the brains of aged CD-1 mice.<xref rid="cit0101" ref-type="bibr">101</xref> Zhu et al conducted a study on a rat model of bilateral carotid artery occlusion induced VD to evaluate the protective effect of lycopene on memory impairment. The study results indicated that chronic administration of lycopene could effectively inhibit oxidative stress and reduce the expression of neuron-restrictive silencer factor (<italic>NRSF</italic>) in rats&#x02019; brains.<xref rid="cit0102" ref-type="bibr">102</xref></p><p>Berberine is an isoquinoline alkaloid extracted from barberry, it has wide medicinal uses in the treatment of bacterial diarrhea, hypercholesterolemia, type 2 diabetes, cardiac disease, and cancer.<xref rid="cit0103" ref-type="bibr">103</xref> Despite many experimental studies elucidating the neuroprotective effects of berberine, its definite mechanism of enhancing memory functions is not fully understood. An in vitro study by Asai et al explored that 10 &#x003bc;mol L<sup>&#x02212;1</sup> berberine could reduce amyloid &#x003b2; levels to 30% via modulation of the amyloid precursor protein (APP) pathway in human neuroglioma H4 cells.<xref rid="cit0104" ref-type="bibr">104</xref> Another in vitro study investigated the potential effect of berberine on A&#x003b2;-induced mitochondrial dysfunction in primary cultured hippocampal neurons. The study findings confirmed that berberine may preserve mitochondrial membrane potential, improve mitochondrial motility and prevent synaptic loss.<xref rid="cit0105" ref-type="bibr">105</xref></p><p>Caffeine is a naturally occurring CNS stimulant found in coffee, tea, and other plants. It has been used for medicinal purposes in many systems of traditional medicine for over thousands of years. Coffee is the main source of caffeine, and it contains phenolics and other bioactive compounds that may have either positive or negative effects on health. Different coffee preparations contain varying levels of caffeine, such as 0.6&#x02013;3.3 mg/mL in espresso, 0.7&#x02013;1.1 mg/mL in boiled or filtered coffee, and 0.2&#x02013;0.6 mg/mL in instant coffee.<xref rid="cit0106" ref-type="bibr">106</xref> Caffeine is absorbed from the gastrointestinal tract rapidly; 99% is absorbed in about 45 min after ingestion.<xref rid="cit0107" ref-type="bibr">107</xref> Caffeine binds with A1 and A2A adenosine receptors. It has positive effects on attention, arousal, mood and vigilance. In high amounts, caffeine can induce anxiety, restlessness, insomnia and psychomotor agitation.<xref rid="cit0108" ref-type="bibr">108</xref> Crude caffeine has higher levels of hydrophilic and lipophilic antioxidant activity than pure caffeine. Caffeine when given in high doses has been reported to inhibit phosphorylation of esterase enzyme which in turn leads to the induction of calcium release from the sarcoplasmic reticulum, thus activating protein kinase A. This cascade of signaling pathways is in the phosphorylation of enzymes involved in glucose and lipid metabolism. Caffeine intake minimizes the risk of cognitive impairment in neurological conditions, including sleep deprivation, alcohol consumption, diabetes, Parkinson&#x02019;s disease, and AD.<xref rid="cit0109" ref-type="bibr">109</xref>,<xref rid="cit0110" ref-type="bibr">110</xref> Several in vitro and in vivo studies reported that caffeine exhibits neuroprotective effects as it protects cortical neurons against A&#x003b2; toxicity as well as prevents A&#x003b2;-induced memory deficits in mice.<xref rid="cit0111" ref-type="bibr">111</xref> A long-term study in mice has supported that as well, showing that caffeine intakes can prevent the memory decline related to age which is associated with changes in neurotrophic factor (BDNF).<xref rid="cit0112" ref-type="bibr">112</xref> It has been reported that caffeine treatment at 40 mg/kg significantly enhances A&#x003b2; clearance (20%) in the brain endothelial cells of C57BL/6 mice.<xref rid="cit0113" ref-type="bibr">113</xref> In another related study, it is found out that caffeine (0.6 mg/d) increases hippocampal mitochondrial respiration (25%) and ATP levels (46%) in the APPSw mice. Caffeine increases hippocampal mitochondrial membrane potential (78%) and decreases ROS production (100%) in Alzheimer&#x02019;s mice.<xref rid="cit0114" ref-type="bibr">114</xref> Caffeine decreased the cholesterol-induced increase in A&#x003b2;, phosphorylated tau, and oxidative stress levels in rabbits&#x02019; hippocampus and reversed the cholesterol-induced decrease in adenosine A1 receptors (A1R) levels when given in the drinking water at 0.5 and 30 mg/day.<xref rid="cit0115" ref-type="bibr">115</xref> Many randomized controlled trials support the potential role of caffeine in improving cognition. A 21-year follow-up study (875 women and 534 men, age 50 years) concluded that moderate consumption (3&#x02013;5 cups) of coffee substantially reduced the risk of AD (62&#x02013;64%) and dementia (65&#x02013;70%) later in life, compared with low coffee consumers (0&#x02013;2 cups).<xref rid="cit0116" ref-type="bibr">116</xref> The consumption of caffeine is linked to faster processing of new information and improved simple reaction time.<xref rid="cit0117" ref-type="bibr">117</xref> In a large prospective cohort study of 2475 females over 65 years old with vascular diseases, the relation between habitual caffeine uses and long-term cognitive decline was examined over five years. As a result, coffee consumption was linked to a slower rate of cognitive decline, especially in women with stable diets.<xref rid="cit0118" ref-type="bibr">118</xref> In another prospective study conducted by the Canadian Study of Health and Aging (CSHA) for five years, daily coffee consumption reduced the risk of AD by 31%.<xref rid="cit0119" ref-type="bibr">119</xref> However, at autopsy, patients who consumed more than 277.5 mg of caffeine a day had a decreased probability of presenting AD-related lesions, or other ischemic lesions.<xref rid="cit0120" ref-type="bibr">120</xref> Caffeine has been found to reduce the risk of developing AD in patients with apolipoprotein E (ApoE &#x003b5;4) allele.<xref rid="cit0121" ref-type="bibr">121</xref> In contrast, a recent study from the Honolulu-Asian Aging Study failed to establish a significant correlation between caffeine consumption and dementia risk.<xref rid="cit0036" ref-type="bibr">36</xref> Similarly, a longitudinal study in the Netherlands reported that no significant correlation between caffeine intake and a reduced risk of cognitive decline.<xref rid="cit0122" ref-type="bibr">122</xref></p><p>In addition to the aforementioned medicinal plants and bioactive candidates (<xref ref-type="fig" rid="f0002">Figure 2</xref>), several marketed herbal formulations are currently used for dementia treatment. Yukmijihwang-tang is a common herbal product in Korea, China and Japan used to enhance memory. It has been found to inhibit apoptosis by enhancing the expression of the neuron-specific proteins transthyretin and PEP-19 in the brains of rats exposed to neurotoxicant.<xref rid="cit0123" ref-type="bibr">123</xref> Another cognitive enhancer herbal formulation is a Chinese Naoweikang, containing <italic>Ginkgo biloba</italic> and <italic>Panax ginseng</italic>. It has been tested and found to modulate the cholinergic pathway against A&#x003b2;<sub>1&#x02013;40</sub> induced neurotoxicity in the brain of Sprague Dawley rats.<xref rid="cit0124" ref-type="bibr">124</xref> ESP-2, a standardized Korean combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis effectively inhibited AChE activity and reversed scopolamine-induced memory impairment in ICR mice.<xref rid="cit0125" ref-type="bibr">125</xref><fig id="f0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical structure of bioactive molecules with potential anti-dementia activity.</p></caption><graphic content-type="print-only" xlink:href="DNND-11-1-g0002"/></fig></p></sec><sec id="s0013"><title>Future Prospective</title><p>Dementias and Alzheimer&#x02019;s disease are closely intertwined multifactorial diseases caused by a cascade of genetic and environmental risk factors developing over a period of time. The heterogeneous nature of factors causing the disease has made it very difficult to find the right treatment as one drug will not be sufficient to make a difference in all related dementias. Therefore, there has not been any substantial progress in the development of a successful line of dementia treatment. The reason behind the multiple failures of clinical trials of drugs targeting memory loss could be attributed to delay in the starting of therapies in the disease progression, ineffective drug doses, incorrect target of the treatment, and most importantly an incomplete understanding of the pathophysiology of memory loss, as well as the progression of neuro-degeneration.</p><p>It is the need of the hour to identify the underlying cause of the disease and to develop alternative approaches targeting multiple pathways of dementia and AD. Herbal drugs could be used as an alternative medicine for the treatment of neurodegenerative disorders and could also help in alleviating the sufferings of the patients. Herbal drugs are less toxic as compared to their synthetic counterparts, bioavailable, have multiple synergistic effects and enhance cognition. However, the variable constituents in medicinal plants and variable preparations based on genetic, cultural and environmental factors are the biggest impediment in the amalgamation of herbal medicines into modern medicines.</p><p>To ensure efficient and ethical care in dementia, psychoeducation, advanced planning for future care needs as well as appropriate pharmaceutical treatment along with environmental and behavioral techniques are instrumental. Several studies are ongoing in full swing for assessment of the benefits of an Alzheimer&#x02019;s vaccine (having component of an antigenic amyloid protein, amyloid enzyme inhibitors and nerve growth factor therapies). These approaches may prove to be promising, however, extensive research needs to be done. It becomes imperative to develop a standardized approach for treating patients individually with the help of detailed research which should focus on identifying the active ingredients of plants and investigating their mechanism of action.</p></sec><sec id="s0014"><title>Conclusions</title><p>Herein, we reviewed the most medicinal plants which are being used in various traditional systems of medicine, and explain the related mechanisms and effects against dementia. All these collective evidences gathered from clinical trials and animal studies support the treasured value of medicinal plants as an alternative strategy for the prevention or treatment of dementia. Herbal plants and phytoactive compounds are superior in terms of safety when compared with synthetic drugs such as donepezil, and considered as promising alternative strategies for improving memory deficits. Animal models of dementia are not sufficient to understand the plausible explanation of these herbal candidates, thus further clinical studies with a larger sample size are required for developing evidence-based medicines for the treatment of dementia and AD.</p></sec></body><back><sec id="s0015" sec-type="COI-statement"><title>Disclosure</title><p>The authors have declared no conflicts of interest for this work.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bilinski</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Herbal medicine for the treatment of vascular dementia: an overview of scientific evidence</article-title>. <source><italic toggle="yes">Evid Based Compl Altern Med</italic></source>. <year>2016</year>;<volume>2016</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2016/7293626</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Tewari</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stankiewicz</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Mocan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sah</surname>
<given-names>AN</given-names></string-name>. <article-title>Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs</article-title>. <source><italic toggle="yes">Front Aging Neurosci</italic></source>. <year>2018</year>;<volume>10</volume>(<issue>3</issue>):<fpage>1</fpage>&#x02013;<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2018.00003</pub-id><pub-id pub-id-type="pmid">29403371</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Rossor</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Mummery</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Schott</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Warren</surname>
<given-names>JD</given-names></string-name>. <article-title>The diagnosis of young-onset dementia</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2010</year>;<volume>9</volume>(<issue>8</issue>):<fpage>793</fpage>&#x02013;<lpage>806</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(10)70159-9</pub-id><pub-id pub-id-type="pmid">20650401</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Tripathi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vibha</surname>
<given-names>D</given-names></string-name>. <article-title>Reversible dementias</article-title>. <source><italic toggle="yes">Indian J Psychiatry</italic></source>. <year>2009</year>;<volume>51</volume>(<issue>Suppl1</issue>):<fpage>S52</fpage>.<pub-id pub-id-type="pmid">21416018</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Iadecola</surname>
<given-names>C</given-names></string-name>. <article-title>The pathobiology of vascular dementia</article-title>. <source><italic toggle="yes">Neuron</italic></source>. <year>2013</year>;<volume>80</volume>(<issue>4</issue>):<fpage>844</fpage>&#x02013;<lpage>866</lpage>.<pub-id pub-id-type="pmid">24267647</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Rivas-Arancibia</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hern&#x000e1;ndez-Zimbr&#x000f3;n</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Rodr&#x000ed;guez-Mart&#x000ed;nez</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Borgonio-P&#x000e9;rez</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Velumani</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Dur&#x000e1;n-Bedolla</surname>
<given-names>J</given-names></string-name>. <article-title>Chronic exposure to low doses of ozone produces a state of oxidative stress and blood-brain barrier damage in the hippocampus of rat</article-title>. <source><italic toggle="yes">Adv Biosci Biotechnol</italic></source>. <year>2013</year>;<volume>04</volume>(<issue>11</issue>):<fpage>24</fpage>&#x02013;<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.4236/abb.2013.411A2004</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Yan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>H</given-names></string-name>. <article-title>Pesticide exposure and risk of alzheimer&#x02019;s disease: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-016-0001-8</pub-id><pub-id pub-id-type="pmid">28442746</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Giri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>L&#x000fc;</surname>
<given-names>Y</given-names></string-name>. <article-title>Genes associated with alzheimer&#x02019;s disease: an overview and current status</article-title>. <source><italic toggle="yes">Clin Interv Aging</italic></source>. <year>2016</year>;<volume>11</volume>:<fpage>665</fpage>&#x02013;<lpage>681</lpage>. doi:<pub-id pub-id-type="doi">10.2147/CIA.S105769</pub-id><pub-id pub-id-type="pmid">27274215</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Mecocci</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tinarelli</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Schulz</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Polidori</surname>
<given-names>MC</given-names></string-name>. <article-title>Nutraceuticals in cognitive impairment and alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">Front Pharmacol</italic></source>. <year>2014</year>;<volume>5 JUN</volume>(<issue>June</issue>):<fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">24478702</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Van Marum</surname>
<given-names>RJ</given-names></string-name>. <article-title>Update on the use of memantine in alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">Neuropsychiatr Dis Treat</italic></source>. <year>2009</year>;<volume>5</volume>(<issue>1</issue>):<fpage>237</fpage>&#x02013;<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NDT.S4048</pub-id><pub-id pub-id-type="pmid">19557118</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Danysz</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Parsons</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>M&#x000f6;bius</surname>
<given-names>H</given-names></string-name>, <string-name><surname>St&#x000f6;ffler</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Quack</surname>
<given-names>G</given-names></string-name>. <article-title>Neuroprotective and symptomatological action of memantine relevant for alzheimer&#x02019;s disease &#x02013; a unified glutamatergic hypothesis on the mechanism of action</article-title>. <source><italic toggle="yes">Neurotox Res</italic></source>. <year>2000</year>;<volume>2</volume>(<issue>2&#x02013;3</issue>):<fpage>85</fpage>&#x02013;<lpage>97</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF03033787</pub-id><pub-id pub-id-type="pmid">16787834</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Guan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Draft genome of the living fossil Ginkgo biloba</article-title>. <source><italic toggle="yes">Gigascience</italic></source>. <year>2016</year>;<volume>5</volume>(<issue>1</issue>):<fpage>49</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13742-016-0154-1</pub-id><pub-id pub-id-type="pmid">27871309</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname>
<given-names>ZK</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>HQ</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>SD</given-names></string-name>. <article-title>Traditional Chinese medicine: a promising candidate for the treatment of alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">Transl Neurodegener</italic></source>. <year>2013</year>;<volume>2</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.1186/2047-9158-2-6</pub-id><pub-id pub-id-type="pmid">23298720</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Holstein</surname>
<given-names>N</given-names></string-name>. <article-title>Ginkgo special extract EGb 761 in tinnitus therapy. An overview of results of completed clinical trials</article-title>. <source><italic toggle="yes">Fortschr Med Orig</italic></source>. <year>2001</year>;<volume>118</volume>(<issue>4</issue>):<fpage>157</fpage>&#x02013;<lpage>164</lpage>.<pub-id pub-id-type="pmid">11217680</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Schneider</surname>
<given-names>B</given-names></string-name>. <article-title>Ginkgo biloba extract in peripheral arterial diseases. Meta-analysis of controlled clinical studies</article-title>. <source><italic toggle="yes">Arzneimittelforschung</italic></source>. <year>1992</year>;<volume>42</volume>(<issue>4</issue>):<fpage>428</fpage>&#x02013;<lpage>436</lpage>.<pub-id pub-id-type="pmid">1386514</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>TY</given-names></string-name>, <string-name><surname>Ayoub</surname>
<given-names>IA</given-names></string-name>, <string-name><surname>Maynard</surname>
<given-names>KI</given-names></string-name>. <article-title>Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats</article-title>. <source><italic toggle="yes">J Neurosci Res</italic></source>. <year>2002</year>;<volume>68</volume>(<issue>5</issue>):<fpage>636</fpage>&#x02013;<lpage>645</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jnr.10251</pub-id><pub-id pub-id-type="pmid">12111854</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Bridi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Crossetti</surname>
<given-names>FP</given-names></string-name>, <string-name><surname>Steffen</surname>
<given-names>VM</given-names></string-name>, <string-name><surname>Henriques</surname>
<given-names>AT</given-names></string-name>. <article-title>The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats</article-title>. <source><italic toggle="yes">Phytother Res</italic></source>. <year>2001</year>;<volume>15</volume>(<issue>5</issue>):<fpage>449</fpage>&#x02013;<lpage>451</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ptr.814</pub-id><pub-id pub-id-type="pmid">11507743</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Domor&#x000e1;kov&#x000e1;</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Burda</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mech&#x000ed;rov&#x000e1;</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ferikov&#x000e1;</surname>
<given-names>M</given-names></string-name>. <article-title>Mapping of rat hippocampal neurons with NeuN after ischemia/reperfusion and Ginkgo biloba extract (EGb 761) pretreatment</article-title>. <source><italic toggle="yes">Cell Mol Neurobiol</italic></source>. <year>2006</year>;<volume>26</volume>(<issue>7&#x02013;8</issue>):<fpage>1193</fpage>&#x02013;<lpage>1204</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10571-006-9080-6</pub-id><pub-id pub-id-type="pmid">16758319</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Ryou</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>YH</given-names></string-name>. <article-title>Effect of Ginkgo biloba leaf powder and extract on plasma and liver lipids, platelet aggregation and erythrocyte Na+ efflux in rats fed hypercholesterolemic diet</article-title>. <source><italic toggle="yes">FASEB J</italic></source>. <year>2011</year>;<volume>25</volume>:<fpage>S1</fpage>.</mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Bastianetto</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>WH</given-names></string-name>, <string-name><surname>Quirion</surname>
<given-names>R</given-names></string-name>. <article-title>The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C</article-title>. <source><italic toggle="yes">J Neurochem</italic></source>. <year>2000</year>;<volume>74</volume>(<issue>6</issue>):<fpage>2268</fpage>&#x02013;<lpage>2277</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0742268.x</pub-id><pub-id pub-id-type="pmid">10820186</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Krieglstein</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ausmeier</surname>
<given-names>F</given-names></string-name>, <string-name><surname>El-Abhar</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Neuroprotective effects of Ginkgo biloba constituents</article-title>. <source><italic toggle="yes">Eur J Pharm Sci</italic></source>. <year>1995</year>;<volume>3</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0928-0987(94)00073-9</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>WR</given-names></string-name>, <string-name><surname>Hayashi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kitagawa</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Protective effect of Ginkgo extract on rat brain with transient middle cerebral artery occlusion</article-title>. <source><italic toggle="yes">Neurol Res</italic></source>. <year>2000</year>;<volume>22</volume>(<issue>5</issue>):<fpage>517</fpage>&#x02013;<lpage>521</lpage>. doi:<pub-id pub-id-type="doi">10.1080/01616412.2000.11740713</pub-id><pub-id pub-id-type="pmid">10935227</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Rocher</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Carr&#x000e9;</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Spinnewyn</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Long-term treatment with standardized Ginkgo biloba extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia</article-title>. <source><italic toggle="yes">Fitoterapia</italic></source>. <year>2011</year>;<volume>82</volume>(<issue>7</issue>):<fpage>1075</fpage>&#x02013;<lpage>1080</lpage>.<pub-id pub-id-type="pmid">21820038</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Mohamed</surname>
<given-names>NES</given-names></string-name>, <string-name><surname>Abd El-Moneim</surname>
<given-names>AE</given-names></string-name>. <article-title>Ginkgo biloba extract alleviates oxidative stress and some neurotransmitters changes induced by aluminum chloride in rats</article-title>. <source><italic toggle="yes">Nutrition</italic></source>. <year>2017</year>;<volume>35</volume>(<issue>93&#x02013;9</issue>). doi:<pub-id pub-id-type="doi">10.1016/j.nut.2016.10.012</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Ribeiro</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Moreira</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Ar&#x000e7;ari</surname>
<given-names>DP</given-names></string-name>, et al. <article-title>Protective effects of chronic treatment with a standardized extract of Ginkgo biloba L. in the prefrontal cortex and dorsal hippocampus of middle-aged rats</article-title>. <source><italic toggle="yes">Behav Brain Res</italic></source>. <year>2016</year>;<volume>313</volume>:<fpage>144</fpage>&#x02013;<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbr.2016.06.029</pub-id><pub-id pub-id-type="pmid">27424157</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Herrschaft</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Nacu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Likhachev</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sholomov</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Hoerr</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Schlaefke</surname>
<given-names>S</given-names></string-name>. <article-title>Ginkgo biloba extract EGb 761 <sup>&#x000ae;</sup> in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg</article-title>. <source><italic toggle="yes">J Psychiatr Res</italic></source>. <year>2012</year>;<volume>46</volume>(<issue>6</issue>):<fpage>716</fpage>&#x02013;<lpage>723</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2012.03.003</pub-id><pub-id pub-id-type="pmid">22459264</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>Efficacy and safety of ginkgo preparation in patients with vascular dementia: a protocol for systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Medicine</italic></source>. <year>2020</year>;<volume>99</volume>(<issue>37</issue>):<fpage>e22209</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000022209</pub-id><pub-id pub-id-type="pmid">32925798</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Gauthier</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schlaefke</surname>
<given-names>S</given-names></string-name>. <article-title>Efficacy and tolerability of Ginkgo biloba extract EGb 761<sup>&#x000ae;</sup> in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials</article-title>. <source><italic toggle="yes">Clin Interv Aging</italic></source>. <year>2014</year>;<volume>9</volume>:<fpage>2065</fpage>&#x02013;<lpage>2077</lpage>. doi:<pub-id pub-id-type="doi">10.2147/CIA.S72728</pub-id><pub-id pub-id-type="pmid">25506211</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Williamson</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Fitzpatrick</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Kronmal</surname>
<given-names>RA</given-names></string-name>, et al. <article-title>Ginkgo biloba for prevention of dementia</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2008</year>;<volume>300</volume>(<issue>19</issue>):<fpage>2253</fpage>&#x02013;<lpage>2262</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2008.683</pub-id><pub-id pub-id-type="pmid">19017911</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration</article-title>. <source><italic toggle="yes">Br J Pharmacol</italic></source>. <year>2013</year>;<volume>170</volume>(<issue>2</issue>):<fpage>440</fpage>&#x02013;<lpage>457</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bph.12285</pub-id><pub-id pub-id-type="pmid">23808355</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Izzo</surname>
<given-names>AA</given-names></string-name>. <article-title>Interactions between herbs and conventional drugs: overview of the clinical data</article-title>. <source><italic toggle="yes">Med Princ Pract</italic></source>. <year>2012</year>;<volume>21</volume>(<issue>5</issue>):<fpage>404</fpage>&#x02013;<lpage>428</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000334488</pub-id><pub-id pub-id-type="pmid">22236736</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Mishra</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>BB</given-names></string-name>, <string-name><surname>Dagenais</surname>
<given-names>S</given-names></string-name>. <article-title>Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review</article-title>. <source><italic toggle="yes">Altern Med Rev</italic></source>. <year>2000</year>;<volume>5</volume>(<issue>4</issue>):<fpage>334</fpage>&#x02013;<lpage>346</lpage>.<pub-id pub-id-type="pmid">10956379</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Farooqui</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Farooqui</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Madan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ong</surname>
<given-names>JHJ</given-names></string-name>, <string-name><surname>Ong</surname>
<given-names>WY</given-names></string-name>. <article-title>Ayurvedic medicine for the treatment of dementia: mechanistic aspects</article-title>. <source><italic toggle="yes">Evid Based Compl Altern Med</italic></source>. <year>2018</year>;<volume>2018</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2018/2481076</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Kuboyama</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tohda</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Komatsu</surname>
<given-names>K</given-names></string-name>. <article-title>Withanoside IV and its active metabolite, sominone, attenuate A&#x003b2;(25&#x02013;35)-induced neurodegeneration</article-title>. <source><italic toggle="yes">Eur J Neurosci</italic></source>. <year>2006</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1417</fpage>&#x02013;<lpage>1426</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04664.x</pub-id><pub-id pub-id-type="pmid">16553605</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Chengappa</surname>
<given-names>KNR</given-names></string-name>, <string-name><surname>Bowie</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Schlicht</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Fleet</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Brar</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Jindal</surname>
<given-names>R</given-names></string-name>. <article-title>Randomized placebo-controlled adjunctive study of an extract of Withania somnifera for cognitive dysfunction in bipolar disorder</article-title>. <source><italic toggle="yes">J Clin Psychiatry</italic></source>. <year>2013</year>;<volume>74</volume>(<issue>11</issue>):<fpage>1076</fpage>&#x02013;<lpage>1083</lpage>. doi:<pub-id pub-id-type="doi">10.4088/JCP.13m08413</pub-id><pub-id pub-id-type="pmid">24330893</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Jung</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>KS</given-names></string-name>. <article-title>Beneficial effects of panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions</article-title>. <source><italic toggle="yes">J Ginseng Res</italic></source>. <year>2018</year>;<volume>42</volume>(<issue>3</issue>):<fpage>239</fpage>&#x02013;<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jgr.2017.03.011</pub-id><pub-id pub-id-type="pmid">29989012</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>San</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>Y</given-names></string-name>. <article-title>Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2007</year>;<volume>115</volume>(<issue>3</issue>):<fpage>441</fpage>&#x02013;<lpage>448</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2007.10.026</pub-id><pub-id pub-id-type="pmid">18083315</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Eckman</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Eckman</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Eckman</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Eckman</surname>
<given-names>CB</given-names></string-name>. <article-title>Reductions in levels of the alzheimer&#x02019;s amyloid &#x003b2; peptide after oral administration of ginsenosides</article-title>. <source><italic toggle="yes">FASEB J</italic></source>. <year>2006</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1269</fpage>&#x02013;<lpage>1271</lpage>. doi:<pub-id pub-id-type="doi">10.1096/fj.05-5530fje</pub-id><pub-id pub-id-type="pmid">16636099</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Chu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses</article-title>. <source><italic toggle="yes">Int Immunopharmacol</italic></source>. <year>2014</year>;<volume>19</volume>(<issue>2</issue>):<fpage>317</fpage>&#x02013;<lpage>326</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.intimp.2014.01.018</pub-id><pub-id pub-id-type="pmid">24503167</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal">Hur JY, Kim SS, Kim KT, et al., inventors; Korea Food Res Inst., assignee. Rg18 pharmaceutical composition for improving preventing or treating a degenerative disease comprising ginsenoside Rg18. Korean patent KR101771679 (B1). 2017 Aug 29.</mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>ZJ</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xue</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>NH</given-names></string-name>. <article-title>Ginsenoside Rg1 promotes glutamate release via a calcium/calmodulin-dependent protein kinase II-dependent signaling pathway</article-title>. <source><italic toggle="yes">Brain Res</italic></source>. <year>2010</year>;<volume>1333</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.brainres.2010.03.096</pub-id><pub-id pub-id-type="pmid">20381470</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Heo</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>K</given-names></string-name>, et al. <article-title>An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">Eur J Neurol</italic></source>. <year>2008</year>;<volume>15</volume>(<issue>8</issue>):<fpage>865</fpage>&#x02013;<lpage>868</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1468-1331.2008.02157.x</pub-id><pub-id pub-id-type="pmid">18684311</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Brondino</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Re</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Boldrini</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies</article-title>. <source><italic toggle="yes">Sci World J</italic></source>. <year>2014</year>;<volume>2014</volume>.</mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Panahi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hosseini</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Khalili</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post-hoc analysis of a randomized controlled trial</article-title>. <source><italic toggle="yes">Biomed Pharmacother</italic></source>. <year>2016</year>;<volume>82</volume>:<fpage>578</fpage>&#x02013;<lpage>582</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopha.2016.05.037</pub-id><pub-id pub-id-type="pmid">27470399</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Park</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>EK</given-names></string-name>, et al. <article-title>Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation</article-title>. <source><italic toggle="yes">Food Chem Toxicol</italic></source>. <year>2008</year>;<volume>46</volume>(<issue>8</issue>):<fpage>2881</fpage>&#x02013;<lpage>2887</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.fct.2008.05.030</pub-id><pub-id pub-id-type="pmid">18573304</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Fiala</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cashman</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Curcuminoids enhance amyloid-&#x003b2; uptake by macrophages of alzheimer&#x02019;s disease patients</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2006</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2006-10101</pub-id><pub-id pub-id-type="pmid">16988474</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Molino</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dossena</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Buonocore</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Polyphenols in dementia: from molecular basis to clinical trials</article-title>. <source><italic toggle="yes">Life Sci</italic></source>. <year>2016</year>;<volume>161</volume>:<fpage>69</fpage>&#x02013;<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.lfs.2016.07.021</pub-id><pub-id pub-id-type="pmid">27493077</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Agrawal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mishra</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Tyagi</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Nath</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Shukla</surname>
<given-names>R</given-names></string-name>. <article-title>Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat</article-title>. <source><italic toggle="yes">Pharmacol Res</italic></source>. <year>2010</year>;<volume>61</volume>(<issue>3</issue>):<fpage>247</fpage>&#x02013;<lpage>252</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phrs.2009.12.008</pub-id><pub-id pub-id-type="pmid">20026275</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Ganguli</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chandra</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Kamboh</surname>
<given-names>MI</given-names></string-name>, et al. <article-title>Apolipoprotein E polymorphism and alzheimer disease: the Indo-US cross-national dementia study</article-title>. <source><italic toggle="yes">Arch Neurol</italic></source>. <year>2000</year>;<volume>57</volume>(<issue>6</issue>):<fpage>824</fpage>&#x02013;<lpage>830</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archneur.57.6.824</pub-id><pub-id pub-id-type="pmid">10867779</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Ringman</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Frautschy</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Teng</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Oral curcumin for alzheimer&#x02019;s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study</article-title>. <source><italic toggle="yes">Alzheimers Res Ther</italic></source>. <year>2012</year>;<volume>4</volume>(<issue>5</issue>):<fpage>43</fpage>. doi:<pub-id pub-id-type="doi">10.1186/alzrt146</pub-id><pub-id pub-id-type="pmid">23107780</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="book"><string-name><surname>&#x000d6;zt&#x000fc;rk</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Altay</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Hakeem</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Ak&#x000e7;i&#x000e7;ek</surname>
<given-names>E</given-names></string-name>. <source><italic toggle="yes">Liquorice: From Botany to Phytochemistry</italic></source>. <publisher-name>Springer</publisher-name>; <year>2019</year>.</mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Mersereau</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Levy</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Staub</surname>
<given-names>RE</given-names></string-name>, et al. <article-title>Liquiritigenin is a plant-derived highly selective estrogen receptor &#x003b2; agonist</article-title>. <source><italic toggle="yes">Mol Cell Endocrinol</italic></source>. <year>2008</year>;<volume>283</volume>(<issue>1&#x02013;2</issue>):<fpage>49</fpage>&#x02013;<lpage>57</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mce.2007.11.020</pub-id><pub-id pub-id-type="pmid">18177995</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Zou</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>L&#x000fc;</surname>
<given-names>QJ</given-names></string-name>. <article-title>Liquiritigenin inhibits A&#x003b2;25&#x02013;35-induced neurotoxicity and secretion of A&#x003b2;1&#x02013;40 in rat hippocampal neurons</article-title>. <source><italic toggle="yes">Acta Pharmacol Sin</italic></source>. <year>2009</year>;<volume>30</volume>(<issue>7</issue>):<fpage>899</fpage>&#x02013;<lpage>906</lpage>. doi:<pub-id pub-id-type="doi">10.1038/aps.2009.74</pub-id><pub-id pub-id-type="pmid">19574995</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Soo</surname>
<given-names>BY</given-names></string-name>, <string-name><surname>Sang</surname>
<given-names>EP</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>SL</given-names></string-name>. <article-title>Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells</article-title>. <source><italic toggle="yes">J Pharmacol Exp Ther</italic></source>. <year>2007</year>;<volume>321</volume>(<issue>2</issue>):<fpage>816</fpage>&#x02013;<lpage>822</lpage>. doi:<pub-id pub-id-type="doi">10.1124/jpet.107.119602</pub-id><pub-id pub-id-type="pmid">17314199</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Danysz</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Parsons</surname>
<given-names>CG</given-names></string-name>. <article-title>The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for alzheimer&#x02019;s disease: preclinical evidence</article-title>. <source><italic toggle="yes">Int J Geriatr Psychiatry</italic></source>. <year>2003</year>;<volume>18</volume>(<issue>S1</issue>):<fpage>S23</fpage>&#x02013;<lpage>S32</lpage>. doi:<pub-id pub-id-type="doi">10.1002/gps.938</pub-id><pub-id pub-id-type="pmid">12973747</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Isemura</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Miyoshi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Pervin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Unno</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>Y</given-names></string-name>. <article-title>Green tea catechins for well-being and therapy: prospects and opportunities</article-title>. <source><italic toggle="yes">Bot Targets Ther</italic></source>. <year>2015</year>;<volume>5</volume>:<fpage>85</fpage>&#x02013;<lpage>96</lpage>. doi:<pub-id pub-id-type="doi">10.2147/BTAT.S91784</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Cascella</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bimonte</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Muzio</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Schiavone</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Cuomo</surname>
<given-names>A</given-names></string-name>. <article-title>The efficacy of epigallocatechin-3-gallate (green tea) in the treatment of alzheimer&#x02019;s disease: an overview of pre-clinical studies and translational perspectives in clinical practice</article-title>. <source><italic toggle="yes">Infect Agent Cancer</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.1186/s13027-017-0145-6</pub-id><pub-id pub-id-type="pmid">28053656</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Biasibetti</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Tramontina</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Costa</surname>
<given-names>AP</given-names></string-name>, et al. <article-title>Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia</article-title>. <source><italic toggle="yes">Behav Brain Res</italic></source>. <year>2013</year>;<volume>236</volume>(<issue>1</issue>):<fpage>186</fpage>&#x02013;<lpage>193</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbr.2012.08.039</pub-id><pub-id pub-id-type="pmid">22964138</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>DY</given-names></string-name>, <string-name><surname>Yun</surname>
<given-names>YP</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Oh</surname>
<given-names>KW</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>JT</given-names></string-name>. <article-title>Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties</article-title>. <source><italic toggle="yes">J Nutr Biochem</italic></source>. <year>2013</year>;<volume>24</volume>(<issue>1</issue>):<fpage>298</fpage>&#x02013;<lpage>310</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jnutbio.2012.06.011</pub-id><pub-id pub-id-type="pmid">22959056</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Tomata</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sugiyama</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kaiho</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Green tea consumption and the risk of incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study</article-title>. <source><italic toggle="yes">Am J Geriatr Psychiatry</italic></source>. <year>2016</year>;<volume>24</volume>(<issue>10</issue>):<fpage>881</fpage>&#x02013;<lpage>889</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jagp.2016.07.009</pub-id><pub-id pub-id-type="pmid">27594507</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>TI</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YK</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>SG</given-names></string-name>, et al. <article-title>l-Theanine, an amino acid in green tea, attenuates &#x003b2;-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-&#x003ba;B pathways</article-title>. <source><italic toggle="yes">Free Radic Biol Med</italic></source>. <year>2009</year>;<volume>47</volume>(<issue>11</issue>):<fpage>1601</fpage>&#x02013;<lpage>1610</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.09.008</pub-id><pub-id pub-id-type="pmid">19766184</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Farzaei</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Bahramsoltani</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Abbasabadi</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Braidy</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Nabavi</surname>
<given-names>SM</given-names></string-name>. <article-title>Role of green tea catechins in prevention of age-related cognitive decline: pharmacological targets and clinical perspective</article-title>. <source><italic toggle="yes">J Cell Physiol</italic></source>. <year>2019</year>;<volume>234</volume>(<issue>3</issue>):<fpage>2447</fpage>&#x02013;<lpage>2459</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcp.27289</pub-id><pub-id pub-id-type="pmid">30187490</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Cox</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Choudhry</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Peacey</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Dietary (-)-epicatechin as a potent inhibitor of &#x003b2;&#x003b3;-secretase amyloid precursor protein processing</article-title>. <source><italic toggle="yes">Neurobiol Aging</italic></source>. <year>2015</year>;<volume>36</volume>(<issue>1</issue>):<fpage>178</fpage>&#x02013;<lpage>187</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.07.032</pub-id><pub-id pub-id-type="pmid">25316600</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Pervin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Unno</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ohishi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tanabe</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Miyoshi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>Y</given-names></string-name>. <article-title>Beneficial effects of green tea catechins on neurodegenerative diseases</article-title>. <source><italic toggle="yes">Molecules</italic></source>. <year>2018</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1</fpage>&#x02013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules23061297</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Russo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Borrelli</surname>
<given-names>F</given-names></string-name>. <article-title>Bacopa monniera, a reputed nootropic plant: an overview</article-title>. <source><italic toggle="yes">Phytomedicine</italic></source>. <year>2005</year>;<volume>12</volume>(<issue>4</issue>):<fpage>305</fpage>&#x02013;<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phymed.2003.12.008</pub-id><pub-id pub-id-type="pmid">15898709</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Dhawan</surname>
<given-names>BN</given-names></string-name>. <article-title>Drugs affecting learning and memory</article-title>. <source><italic toggle="yes">Lect Neurobiol</italic></source>. <year>1992</year>;<volume>1</volume>:<fpage>189</fpage>&#x02013;<lpage>207</lpage>.</mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Holcomb</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Dhanasekaran</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hitt</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Riggs</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Manyam</surname>
<given-names>BV</given-names></string-name>. <article-title>Bacopa monniera extract reduces amyloid levels in PSAPP mice</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2006</year>;<volume>9</volume>(<issue>3</issue>):<fpage>243</fpage>&#x02013;<lpage>251</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2006-9303</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Limpeanchob</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Jaipan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rattanakaruna</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Phrompittayarat</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ingkaninan</surname>
<given-names>K</given-names></string-name>. <article-title>Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2008</year>;<volume>120</volume>(<issue>1</issue>):<fpage>112</fpage>&#x02013;<lpage>117</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2008.07.039</pub-id><pub-id pub-id-type="pmid">18755259</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Khan</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences</article-title>. <source><italic toggle="yes">Metab Brain Dis</italic></source>. <year>2015</year>;<volume>30</volume>(<issue>1</issue>):<fpage>115</fpage>&#x02013;<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11011-014-9593-5</pub-id><pub-id pub-id-type="pmid">25037167</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Pham</surname>
<given-names>HTN</given-names></string-name>, <string-name><surname>Phan</surname>
<given-names>SV</given-names></string-name>, <string-name><surname>Tran</surname>
<given-names>HN</given-names></string-name>, et al. <article-title>Bacopa monnieri (L.) ameliorates cognitive deficits caused in a trimethyltin-induced neurotoxicity model mice</article-title>. <source><italic toggle="yes">Biol Pharm Bull</italic></source>. <year>2019</year>;<volume>42</volume>(<issue>8</issue>):<fpage>1384</fpage>&#x02013;<lpage>1393</lpage>. doi:<pub-id pub-id-type="doi">10.1248/bpb.b19-00288</pub-id><pub-id pub-id-type="pmid">31366873</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Uabundit</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wattanathorn</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mucimapura</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ingkaninan</surname>
<given-names>K</given-names></string-name>. <article-title>Cognitive enhancement and neuroprotective effects of Bacopa monnieri in alzheimer&#x02019;s disease model</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2010</year>;<volume>127</volume>(<issue>1</issue>):<fpage>26</fpage>&#x02013;<lpage>31</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2009.09.056</pub-id><pub-id pub-id-type="pmid">19808086</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>Kamkaew</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Scholfield</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Ingkaninan</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Bacopa monnieri and its constituents is hypotensive in anaesthetized rats and vasodilator in various artery types</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2011</year>;<volume>137</volume>(<issue>1</issue>):<fpage>790</fpage>&#x02013;<lpage>795</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2011.06.045</pub-id><pub-id pub-id-type="pmid">21762768</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Saha</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Sarkar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jeyasri</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Muthuramalingam</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ramesh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jha</surname>
<given-names>S</given-names></string-name>. <article-title>In vitro propagation, phytochemical and neuropharmacological profiles of Bacopa monnieri (L.) Wettst.: a review</article-title>. <source><italic toggle="yes">Plants</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>4</issue>):<fpage>411</fpage>. doi:<pub-id pub-id-type="doi">10.3390/plants9040411</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Kamkaew</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Norman Scholfield</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ingkaninan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Taepavarapruk</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Chootip</surname>
<given-names>K</given-names></string-name>. <article-title>Bacopa monnieri increases cerebral blood flow in rat independent of blood pressure</article-title>. <source><italic toggle="yes">Phytother Res</italic></source>. <year>2013</year>;<volume>27</volume>(<issue>1</issue>):<fpage>135</fpage>&#x02013;<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ptr.4685</pub-id><pub-id pub-id-type="pmid">22447676</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Calabrese</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gregory</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Leo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kraemer</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bone</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Oken</surname>
<given-names>B</given-names></string-name>. <article-title>Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial</article-title>. <source><italic toggle="yes">J Altern Complement Med</italic></source>. <year>2008</year>;<volume>14</volume>(<issue>6</issue>):<fpage>707</fpage>&#x02013;<lpage>713</lpage>. doi:<pub-id pub-id-type="doi">10.1089/acm.2008.0018</pub-id><pub-id pub-id-type="pmid">18611150</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Kumar</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Abichandani</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Thawani</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gharpure</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Naidu</surname>
<given-names>MUR</given-names></string-name>, <string-name><surname>Venkat Ramana</surname>
<given-names>G</given-names></string-name>. <article-title>Efficacy of standardized extract of Bacopa monnieri (Bacognize<sup>&#x000ae;</sup>) on cognitive functions of medical students: a six-week, randomized placebo-controlled trial</article-title>. <source><italic toggle="yes">Evid Based Compl Altern Med</italic></source>. <year>2016</year>;<volume>2016</volume>.</mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Thakkar</surname>
<given-names>VT</given-names></string-name>, <string-name><surname>Deshmukh</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hingorani</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Development and optimization of dispersible tablet of Bacopa monnieri with improved functionality for memory enhancement</article-title>. <source><italic toggle="yes">J Pharm Bioallied Sci</italic></source>. <year>2017</year>;<volume>9</volume>(<issue>3</issue>):<fpage>208</fpage>. doi:<pub-id pub-id-type="doi">10.4103/jpbs.JPBS_8_17</pub-id><pub-id pub-id-type="pmid">28979076</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Sharma</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chaturvedi</surname>
<given-names>C</given-names></string-name>. <article-title>Efficacy of Bacopa monniera in revitalizing intellectual functions in children</article-title>. <source><italic toggle="yes">J Res Edu Ind Med</italic></source>. <year>1987</year>;<volume>1</volume>:<fpage>2</fpage>.</mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>Kongkeaw</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dilokthornsakul</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Thanarangsarit</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Limpeanchob</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Norman Scholfield</surname>
<given-names>C</given-names></string-name>. <article-title>Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2014</year>;<volume>151</volume>(<issue>1</issue>):<fpage>528</fpage>&#x02013;<lpage>535</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2013.11.008</pub-id><pub-id pub-id-type="pmid">24252493</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><string-name><surname>Mitra-Ganguli</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kalita</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bhushan</surname>
<given-names>S</given-names></string-name>, et al. <article-title>A randomized, double-blind study assessing changes in cognitive function in Indian school children receiving a combination of Bacopa monnieri and micronutrient supplementation vs. placebo</article-title>. <source><italic toggle="yes">Front Pharmacol</italic></source>. <year>2017</year>;<volume>8</volume>(<issue>NOV</issue>):<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">28149278</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>Morgan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Stevens</surname>
<given-names>J</given-names></string-name>. <article-title>Does bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial</article-title>. <source><italic toggle="yes">J Altern Complement Med</italic></source>. <year>2010</year>;<volume>16</volume>(<issue>7</issue>):<fpage>753</fpage>&#x02013;<lpage>759</lpage>. doi:<pub-id pub-id-type="doi">10.1089/acm.2009.0342</pub-id><pub-id pub-id-type="pmid">20590480</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>Joshua Allan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Damodaran</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Deshmukh</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Goudar</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Amit</surname>
<given-names>A</given-names></string-name>. <article-title>Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague-Dawley rats</article-title>. <source><italic toggle="yes">Food Chem Toxicol</italic></source>. <year>2007</year>;<volume>45</volume>(<issue>10</issue>):<fpage>1928</fpage>&#x02013;<lpage>1937</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.fct.2007.04.010</pub-id><pub-id pub-id-type="pmid">17560704</pub-id></mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><string-name><surname>Sahak</surname>
<given-names>MKA</given-names></string-name>, <string-name><surname>Kabir</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Abbas</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Draman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hashim</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>Hasan Adli</surname>
<given-names>DS</given-names></string-name>. <article-title>The role of Nigella sativa and its active constituents in learning and memory</article-title>. <source><italic toggle="yes">Evid Based Compl Altern Med</italic></source>. <year>2016</year>;<volume>2016</volume>.</mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><string-name><surname>Ali</surname>
<given-names>BH</given-names></string-name>, <string-name><surname>Blunden</surname>
<given-names>G</given-names></string-name>. <article-title>Pharmacological and toxicological properties of Nigella sativa</article-title>. <source><italic toggle="yes">Phytother Res</italic></source>. <year>2003</year>;<volume>17</volume>(<issue>4</issue>):<fpage>299</fpage>&#x02013;<lpage>305</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ptr.1309</pub-id><pub-id pub-id-type="pmid">12722128</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="book"><string-name><surname>Rajabian</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hosseinzadeh</surname>
<given-names>H</given-names></string-name>. <chapter-title>Dermatological effects of Nigella sativa and its constituent, thymoquinone</chapter-title>. In:&#x000a0;Preedy VR, Watson RR, editors. <source><italic toggle="yes">Nuts and Seeds in Health and Disease Prevention</italic></source>. <publisher-name>Elsevier Inc.</publisher-name>;<year>2020</year>:<fpage>329</fpage>&#x02013;<lpage>355</lpage>.</mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><string-name><surname>Azizi</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Ebrahimi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Saadatfar</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kamalinejad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Majlessi</surname>
<given-names>N</given-names></string-name>. <article-title>Cognitive-enhancing activity of thymol and carvacrol in two rat models of dementia</article-title>. <source><italic toggle="yes">Behav Pharmacol</italic></source>. <year>2012</year>;<volume>23</volume>(<issue>3</issue>):<fpage>241</fpage>&#x02013;<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.1097/FBP.0b013e3283534301</pub-id><pub-id pub-id-type="pmid">22470103</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><string-name><surname>Rendeiro</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Foley</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lau</surname>
<given-names>VC</given-names></string-name>, et al. <article-title>A role for hippocampal PSA-NCAM and NMDA-NR2B receptor function in flavonoid-induced spatial memory improvements in young rats</article-title>. <source><italic toggle="yes">Neuropharmacology</italic></source>. <year>2014</year>;<volume>79</volume>:<fpage>335</fpage>&#x02013;<lpage>344</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.12.003</pub-id><pub-id pub-id-type="pmid">24333331</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><string-name><surname>Hosseini</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mohammadpour</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Karami</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rajaei</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Reza Sadeghnia</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Soukhtanloo</surname>
<given-names>M</given-names></string-name>. <article-title>Effects of the hydro-alcoholic extract of Nigella sativa on scopolamine-induced spatial memory impairment in rats and its possible mechanism</article-title>. <source><italic toggle="yes">Chin J Integr Med</italic></source>. <year>2015</year>;<volume>21</volume>(<issue>6</issue>):<fpage>438</fpage>&#x02013;<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11655-014-1742-5</pub-id><pub-id pub-id-type="pmid">24584756</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><string-name><surname>Khan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khuwaja</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>MB</given-names></string-name>. <article-title>Effect of thymoquinone on streptozotocin model of cognitive impairment in rats</article-title>. <source><italic toggle="yes">Ann Neurosci</italic></source>. <year>2008</year>;<volume>15</volume>:<fpage>94</fpage>.</mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><string-name><surname>Alhebshi</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Gotoh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>I</given-names></string-name>. <article-title>Thymoquinone protects cultured rat primary neurons against amyloid &#x003b2;-induced neurotoxicity</article-title>. <source><italic toggle="yes">Biochem Biophys Res Commun</italic></source>. <year>2013</year>;<volume>433</volume>(<issue>4</issue>):<fpage>362</fpage>&#x02013;<lpage>367</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbrc.2012.11.139</pub-id><pub-id pub-id-type="pmid">23537659</pub-id></mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><string-name><surname>Bin Sayeed</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Shams</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fahim Hossain</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Nigella sativa L. seeds modulate mood, anxiety and cognition in healthy adolescent males</article-title>. <source><italic toggle="yes">J Ethnopharmacol</italic></source>. <year>2014</year>;<volume>152</volume>(<issue>1</issue>):<fpage>156</fpage>&#x02013;<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jep.2013.12.050</pub-id><pub-id pub-id-type="pmid">24412554</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><string-name><surname>Mazzanti</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Di Giacomo</surname>
<given-names>S</given-names></string-name>. <article-title>Curcumin and resveratrol in the management of cognitive disorders: what is the clinical evidence?</article-title>
<source><italic toggle="yes">Molecules</italic></source>. <year>2016</year>;<volume>21</volume>(<issue>9</issue>):<fpage>1</fpage>&#x02013;<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules21091243</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><string-name><surname>Al-Edresi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Alsalahat</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Freeman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Aojula</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Penny</surname>
<given-names>J</given-names></string-name>. <article-title>Resveratrol-mediated cleavage of amyloid &#x003b2;1&#x02013;42 peptide: potential relevance to alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">Neurobiol Aging</italic></source>. <year>2020</year>;<volume>94</volume>:<fpage>24</fpage>&#x02013;<lpage>33</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2020.04.012</pub-id><pub-id pub-id-type="pmid">32512325</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><string-name><surname>Rahman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Almalki</surname>
<given-names>WH</given-names></string-name>, <string-name><surname>Afzal</surname>
<given-names>O</given-names></string-name>, et al. <article-title>Cationic solid lipid nanoparticles of resveratrol for hepatocellular carcinoma treatment: systematic optimization, in vitro characterization and preclinical investigation</article-title>. <source><italic toggle="yes">Int J Nanomedicine</italic></source>. <year>2020</year>;<volume>15</volume>:<fpage>9283</fpage>&#x02013;<lpage>9299</lpage>. doi:<pub-id pub-id-type="doi">10.2147/IJN.S277545</pub-id><pub-id pub-id-type="pmid">33262588</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="journal"><string-name><surname>Feng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>XP</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>SG</given-names></string-name>, et al. <article-title>Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation</article-title>. <source><italic toggle="yes">Neurotoxicology</italic></source>. <year>2009</year>;<volume>30</volume>(<issue>6</issue>):<fpage>986</fpage>&#x02013;<lpage>995</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuro.2009.08.013</pub-id><pub-id pub-id-type="pmid">19744518</pub-id></mixed-citation></ref><ref id="cit0096"><label>96.</label><mixed-citation publication-type="journal"><string-name><surname>Vingtdeux</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Giliberto</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>H</given-names></string-name>, et al. <article-title>AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-&#x003b2; peptide metabolism</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2010</year>;<volume>285</volume>(<issue>12</issue>):<fpage>9100</fpage>&#x02013;<lpage>9113</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M109.060061</pub-id><pub-id pub-id-type="pmid">20080969</pub-id></mixed-citation></ref><ref id="cit0097"><label>97.</label><mixed-citation publication-type="journal"><string-name><surname>Saini</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Rengasamy</surname>
<given-names>KRR</given-names></string-name>, <string-name><surname>Mahomoodally</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Keum</surname>
<given-names>YS</given-names></string-name>. <article-title>Protective effects of lycopene in cancer, cardiovascular, and neurodegenerative diseases: an update on epidemiological and mechanistic perspectives</article-title>. <source><italic toggle="yes">Pharmacol Res</italic></source>. <year>2020</year>;<volume>155</volume>(<issue>October2019</issue>):<fpage>104730</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104730</pub-id><pub-id pub-id-type="pmid">32126272</pub-id></mixed-citation></ref><ref id="cit0098"><label>98.</label><mixed-citation publication-type="journal"><string-name><surname>Alhalmi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Beg</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kohli</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Waris</surname>
<given-names>MS</given-names></string-name>. <article-title>Nanotechnology based approach for hepatocellular carcinoma targeting</article-title>. <source><italic toggle="yes">Curr Drug Targets</italic></source>. <year>2021</year>;<volume>22</volume>:<fpage>1</fpage>.</mixed-citation></ref><ref id="cit0099"><label>99.</label><mixed-citation publication-type="journal"><string-name><surname>Graff</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Pettersson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lis</surname>
<given-names>RT</given-names></string-name>, et al. <article-title>Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression</article-title>. <source><italic toggle="yes">Am J Clin Nutr</italic></source>. <year>2016</year>;<volume>103</volume>(<issue>3</issue>):<fpage>851</fpage>&#x02013;<lpage>860</lpage>. doi:<pub-id pub-id-type="doi">10.3945/ajcn.115.118703</pub-id><pub-id pub-id-type="pmid">26817504</pub-id></mixed-citation></ref><ref id="cit0100"><label>100.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pradhan</surname>
<given-names>AD</given-names></string-name>, et al. <article-title>Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2006</year>;<volume>164</volume>(<issue>6</issue>):<fpage>576</fpage>&#x02013;<lpage>585</lpage>. doi:<pub-id pub-id-type="doi">10.1093/aje/kwj240</pub-id><pub-id pub-id-type="pmid">16801375</pub-id></mixed-citation></ref><ref id="cit0101"><label>101.</label><mixed-citation publication-type="journal"><string-name><surname>Lei</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Lei</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>Y</given-names></string-name>. <article-title>Neuroprotective effects of lycopene pretreatment on transient global cerebral ischemia-reperfusion in rats: the role of the Nrf2/HO-1 signaling pathway</article-title>. <source><italic toggle="yes">Mol Med Rep</italic></source>. <year>2016</year>;<volume>13</volume>(<issue>1</issue>):<fpage>412</fpage>&#x02013;<lpage>418</lpage>. doi:<pub-id pub-id-type="doi">10.3892/mmr.2015.4534</pub-id><pub-id pub-id-type="pmid">26572165</pub-id></mixed-citation></ref><ref id="cit0102"><label>102.</label><mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>NW</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>XL</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Possible mechanisms of lycopene amelioration of learning and memory impairment in rats with vascular dementia</article-title>. <source><italic toggle="yes">Neural Regen Res</italic></source>. <year>2020</year>;<volume>15</volume>(<issue>2</issue>):<fpage>332</fpage>&#x02013;<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.4103/1673-5374.265565</pub-id><pub-id pub-id-type="pmid">31552907</pub-id></mixed-citation></ref><ref id="cit0103"><label>103.</label><mixed-citation publication-type="journal"><string-name><surname>Jiang</surname>
<given-names>WX</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>XJ</given-names></string-name>. <article-title>Therapeutic potential of berberine against neurodegenerative diseases</article-title>. <source><italic toggle="yes">Sci China Life Sci</italic></source>. <year>2015</year>;<volume>58</volume>(<issue>6</issue>):<fpage>564</fpage>&#x02013;<lpage>569</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11427-015-4829-0</pub-id><pub-id pub-id-type="pmid">25749423</pub-id></mixed-citation></ref><ref id="cit0104"><label>104.</label><mixed-citation publication-type="journal"><string-name><surname>Asai</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Iwata</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Yoshikawa</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Berberine alters the processing of alzheimer&#x02019;s amyloid precursor protein to decrease A&#x003b2; secretion</article-title>. <source><italic toggle="yes">Biochem Biophys Res Commun</italic></source>. <year>2007</year>;<volume>352</volume>(<issue>2</issue>):<fpage>498</fpage>&#x02013;<lpage>502</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbrc.2006.11.043</pub-id><pub-id pub-id-type="pmid">17125739</pub-id></mixed-citation></ref><ref id="cit0105"><label>105.</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Lv</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Berberine alleviates amyloid &#x003b2; -induced mitochondrial dysfunction and synaptic loss</article-title>. <source><italic toggle="yes">Oxid Med Cell Longev</italic></source>. <year>2019</year>;<volume>2019</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2019/7593608</pub-id></mixed-citation></ref><ref id="cit0106"><label>106.</label><mixed-citation publication-type="journal"><string-name><surname>Eskelinen</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Kivipelto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cunha</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>de Mendon&#x000e7;a</surname>
<given-names>A</given-names></string-name>. <article-title>Caffeine as a protective factor in dementia and alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2010</year>;<volume>20</volume>(<issue>SUPPL. s1</issue>):<fpage>S167</fpage>&#x02013;<lpage>S174</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2010-1404</pub-id><pub-id pub-id-type="pmid">20182054</pub-id></mixed-citation></ref><ref id="cit0107"><label>107.</label><mixed-citation publication-type="journal"><string-name><surname>Fredholm</surname>
<given-names>BB</given-names></string-name>, <string-name><surname>B&#x000e4;ttig</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Holm&#x000e9;n</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Nehlig</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zvartau</surname>
<given-names>EE</given-names></string-name>. <article-title>Actions of caffeine in the brain with special reference to factors that contribute to its widespread use</article-title>. <source><italic toggle="yes">Pharmacol Rev</italic></source>. <year>1999</year>;<volume>51</volume>(<issue>1</issue>):<fpage>83</fpage>&#x02013;<lpage>133</lpage>.<pub-id pub-id-type="pmid">10049999</pub-id></mixed-citation></ref><ref id="cit0108"><label>108.</label><mixed-citation publication-type="journal"><string-name><surname>Lara</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Cunha</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>de Mendon&#x000e7;a</surname>
<given-names>A</given-names></string-name>. <article-title>Caffeine, mental health, and psychiatric disorders</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2010</year>;<volume>20</volume>(<issue>SUPPL. s1</issue>):<fpage>S239</fpage>&#x02013;<lpage>S248</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2010-1378</pub-id><pub-id pub-id-type="pmid">20164571</pub-id></mixed-citation></ref><ref id="cit0109"><label>109.</label><mixed-citation publication-type="journal"><string-name><surname>Alhaider</surname>
<given-names>IA</given-names></string-name>, <string-name><surname>Aleisa</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Tran</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Alzoubi</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Alkadhi</surname>
<given-names>KA</given-names></string-name>. <article-title>Chronic-caffeine-treatment-prevents-sleep-deprivation-induced-imp-2010</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2018</year>;<volume>33</volume>(<issue>4</issue>):<fpage>437</fpage>&#x02013;<lpage>444</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/33.4.437</pub-id></mixed-citation></ref><ref id="cit0110"><label>110.</label><mixed-citation publication-type="journal"><string-name><surname>Duarte</surname>
<given-names>JMN</given-names></string-name>, <string-name><surname>Carvalho</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Cunha</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Gruetter</surname>
<given-names>R</given-names></string-name>. <article-title>Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats</article-title>. <source><italic toggle="yes">J Neurochem</italic></source>. <year>2009</year>;<volume>111</volume>(<issue>2</issue>):<fpage>368</fpage>&#x02013;<lpage>379</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06349.x</pub-id><pub-id pub-id-type="pmid">19694901</pub-id></mixed-citation></ref><ref id="cit0111"><label>111.</label><mixed-citation publication-type="journal"><string-name><surname>Arendash</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Schleif</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Rezai-Zadeh</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Caffeine protects alzheimer&#x02019;s mice against cognitive impairment and reduces brain &#x003b2;-amyloid production</article-title>. <source><italic toggle="yes">Neuroscience</italic></source>. <year>2006</year>;<volume>142</volume>(<issue>4</issue>):<fpage>941</fpage>&#x02013;<lpage>952</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.07.021</pub-id><pub-id pub-id-type="pmid">16938404</pub-id></mixed-citation></ref><ref id="cit0112"><label>112.</label><mixed-citation publication-type="journal"><string-name><surname>Costa</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Botton</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Mioranzza</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus</article-title>. <source><italic toggle="yes">Neurochem Int</italic></source>. <year>2008</year>;<volume>53</volume>(<issue>3&#x02013;4</issue>):<fpage>89</fpage>&#x02013;<lpage>94</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuint.2008.06.006</pub-id><pub-id pub-id-type="pmid">18620014</pub-id></mixed-citation></ref><ref id="cit0113"><label>113.</label><mixed-citation publication-type="journal"><string-name><surname>Qosa</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Abuznait</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Hill</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Kaddoumi</surname>
<given-names>A</given-names></string-name>. <article-title>Enhanced brain amyloid-&#x003b2; clearance by rifampicin and caffeine as a possible protective mechanism against alzheimer&#x02019;s disease</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2012</year>;<volume>31</volume>(<issue>1</issue>):<fpage>151</fpage>&#x02013;<lpage>165</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2012-120319</pub-id><pub-id pub-id-type="pmid">22504320</pub-id></mixed-citation></ref><ref id="cit0114"><label>114.</label><mixed-citation publication-type="journal"><string-name><surname>Dragicevic</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Delic</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Cao</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in alzheimer&#x02019;s mice and cells</article-title>. <source><italic toggle="yes">Neuropharmacology</italic></source>. <year>2012</year>;<volume>63</volume>(<issue>8</issue>):<fpage>1368</fpage>&#x02013;<lpage>1379</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.08.018</pub-id><pub-id pub-id-type="pmid">22959965</pub-id></mixed-citation></ref><ref id="cit0115"><label>115.</label><mixed-citation publication-type="journal"><string-name><surname>Prasanthi</surname>
<given-names>JRP</given-names></string-name>, <string-name><surname>Dasari</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Marwarha</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Caffeine protects against oxidative stress and alzheimer&#x02019;s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet</article-title>. <source><italic toggle="yes">Free Radic Biol Med</italic></source>. <year>2010</year>;<volume>49</volume>(<issue>7</issue>):<fpage>1212</fpage>&#x02013;<lpage>1220</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.07.007</pub-id><pub-id pub-id-type="pmid">20638472</pub-id></mixed-citation></ref><ref id="cit0116"><label>116.</label><mixed-citation publication-type="journal"><string-name><surname>Eskelinen</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Ngandu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tuomilehto</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Soininen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kivipelto</surname>
<given-names>M</given-names></string-name>. <article-title>Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2009</year>;<volume>16</volume>(<issue>1</issue>):<fpage>85</fpage>&#x02013;<lpage>91</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2009-0920</pub-id><pub-id pub-id-type="pmid">19158424</pub-id></mixed-citation></ref><ref id="cit0117"><label>117.</label><mixed-citation publication-type="journal"><string-name><surname>Smith</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Christopher</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Sutherland</surname>
<given-names>D</given-names></string-name>. <article-title>Acute effects of caffeine on attention: a comparison of non-consumers and withdrawn consumers</article-title>. <source><italic toggle="yes">J Psychopharmacol</italic></source>. <year>2013</year>;<volume>27</volume>(<issue>1</issue>):<fpage>77</fpage>&#x02013;<lpage>83</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0269881112460112</pub-id><pub-id pub-id-type="pmid">22992376</pub-id></mixed-citation></ref><ref id="cit0118"><label>118.</label><mixed-citation publication-type="journal"><string-name><surname>Vercambre</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Berr</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ritchie</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>JH</given-names></string-name>. <article-title>Caffeine and cognitive decline in elderly women at high vascular risk</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2013</year>;<volume>35</volume>(<issue>2</issue>):<fpage>413</fpage>&#x02013;<lpage>421</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-122371</pub-id><pub-id pub-id-type="pmid">23422357</pub-id></mixed-citation></ref><ref id="cit0119"><label>119.</label><mixed-citation publication-type="journal"><string-name><surname>Lindsay</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Laurin</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Verreault</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Risk factors for alzheimer&#x02019;s disease: a prospective analysis from the Canadian Study of Health and Aging</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2002</year>;<volume>156</volume>(<issue>5</issue>):<fpage>445</fpage>&#x02013;<lpage>453</lpage>. doi:<pub-id pub-id-type="doi">10.1093/aje/kwf074</pub-id><pub-id pub-id-type="pmid">12196314</pub-id></mixed-citation></ref><ref id="cit0120"><label>120.</label><mixed-citation publication-type="journal"><string-name><surname>Gelber</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Petrovitch</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Masaki</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Ross</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>White</surname>
<given-names>LR</given-names></string-name>. <article-title>Coffee intake in midlife and risk of dementia and its neuropathologic correlates</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2011</year>;<volume>23</volume>(<issue>4</issue>):<fpage>607</fpage>&#x02013;<lpage>615</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-2010-101428</pub-id><pub-id pub-id-type="pmid">21157028</pub-id></mixed-citation></ref><ref id="cit0121"><label>121.</label><mixed-citation publication-type="journal">Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. <italic>Science</italic>. 1993;261(5123):921-923. doi:<pub-id pub-id-type="doi">10.1126/science.8346443</pub-id></mixed-citation></ref><ref id="cit0122"><label>122.</label><mixed-citation publication-type="journal"><string-name><surname>Van Boxtel</surname>
<given-names>MPJ</given-names></string-name>, <string-name><surname>Schmitt</surname>
<given-names>JAJ</given-names></string-name>, <string-name><surname>Bosma</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Jolles</surname>
<given-names>J</given-names></string-name>. <article-title>The effects of habitual caffeine use on cognitive change: a longitudinal perspective</article-title>. <source><italic toggle="yes">Pharmacol Biochem Behav</italic></source>. <year>2003</year>;<volume>75</volume>(<issue>4</issue>):<fpage>921</fpage>&#x02013;<lpage>927</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0091-3057(03)00171-0</pub-id><pub-id pub-id-type="pmid">12957237</pub-id></mixed-citation></ref><ref id="cit0123"><label>123.</label><mixed-citation publication-type="journal"><string-name><surname>Rho</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Effects of Yukmijihwang-tang derivatives (YMJd), a memory enhancing herbal extract, on the gene-expression profile in the rat hippocampus</article-title>. <source><italic toggle="yes">Biol Pharm Bull</italic></source>. <year>2005</year>;<volume>28</volume>(<issue>1</issue>):<fpage>87</fpage>&#x02013;<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1248/bpb.28.87</pub-id><pub-id pub-id-type="pmid">15635169</pub-id></mixed-citation></ref><ref id="cit0124"><label>124.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>JX</given-names></string-name>, <string-name><surname>Cong</surname>
<given-names>WH</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>JN</given-names></string-name>. <article-title>Effect of combination of extracts of ginseng and ginkgo biloba on acetylcholine in amyloid beta-protein-treated rats determined by an improved HPLC</article-title>. <source><italic toggle="yes">Acta Pharmacol Sin</italic></source>. <year>2004</year>;<volume>25</volume>(<issue>9</issue>):<fpage>1118</fpage>&#x02013;<lpage>1123</lpage>.<pub-id pub-id-type="pmid">15339385</pub-id></mixed-citation></ref><ref id="cit0125"><label>125.</label><mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>KY</given-names></string-name>, <string-name><surname>Koo</surname>
<given-names>KA</given-names></string-name>, et al. <article-title>ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice</article-title>. <source><italic toggle="yes">Life Sci</italic></source>. <year>2005</year>;<volume>76</volume>(<issue>15</issue>):<fpage>1691</fpage>&#x02013;<lpage>1705</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.lfs.2004.07.029</pub-id><pub-id pub-id-type="pmid">15698848</pub-id></mixed-citation></ref></ref-list></back></article>